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ABSTRACT 
Gerald Gianutsos, Ph.D.: Mechanism and Characteristics of 
Drug-Induced Aggression. 
This research investigated the pharmacological alter-
ation of drug-induced aggression in naive, morphine-dependent 
and chronically haloperidol treated rats. Naive rats were 
treated with apomorphine (1.25 - 20 mg/Kg) and aggregated in 
groups of four for aggression. It was determined that 20 
mg/Kg of apomorphine produced maximal aggression, as measured 
by number of attacks, duration of aggressive posturing and 
number of vocalizations. Doses less than 5 mg/Kg were with-
out any effect. The neuroleptics, haloperidol and oxyperomide, 
the narcotic, morphine, and the cholinergic agonist, pilo-
carpine all reduced apomorphine-induced aggression in a dose-
dependent manner. Centrally acting anti-cholinergic drugs 
partially reversed the blockade of aggression produced by 
all the drugs except morphine which was preferentially antag-
onized by naloxone, a narcotic antagonist. Aggression was 
elicited by sub-threshold doses of apomorphine when com-
bined with clonidine; large doses of dexetimide, an anti-
cholinergic; or when administered three days after an injec-
tion of p-chloroamphetamine (12 mg/Kg). None of these drugs 
were capable of eliciting aggression by themselves. Amphet-
am.ine potentiated the apomorphine-induced aggression, but 
failed to elicit aggression with sub-threshold doses of apo-
morphine unless combined with cyproheptadine. 
I n morphine-dependent rats, aggression was observed dur-
ing withdrawal produced by withholding of injections, but not 
in withdrawal induced by naloxone . The aggression - which was 
observed at 72 hours and at 30 days of withdrawal - was re-
duced by morphine, haloperidol or by lesions of the dopamin-
ergic nigro-striatal bundle, and enhanced by small doses of 
apomorphine. Apomorphine was also capable of eliciting aggres-
sion when administered at four hours of withdrawal, with or 
without naloxone. The 72 hour withdrawal aggression was 
similar to apomorphine-induced aggression in naive rats since 
it was dose-dependently increased by dexetimide or clonidine 
and decreased by pilocarpine. However, in contrast to the 
effect in naive rats, anticholinergic drugs failed to reverse 
the blockade of aggression produced by haloperidol in morphine 
dependent rats. 
Following chronic treatment with haloperidol, rats dem-
onstrated signs of dopaminergic supersensitivity as shown 
by enhanced apomorphine- or amphetamine-induced stereotypy, 
increased spontaneous hyperactivity and a shift to the left 
of the dose-response curve for amphetamine stimulation and 
for apomorphine-induced reduction in striatal dopamine turn-
over. In addition, the rats exhibited an increased sensitiv-
ity to the stimulation of activity produced by dexetimide 
and a decrease in the depression of activity produced by 
pilocarpine. Although there was no spontaneous aggression 
after discontinuation of chronic halperidol, the threshold 
dose of apomorphine required to elicit aggression was drama-
tically reduced. Amphetamine failed to produce aggression 
after chronic haloperidol, in contrast to the effect normally 
seen after chronic morphine. 
The results of this study demonstrated the requirement 
of central dopaminergic stimulation for drug-induced aggression, 
and suggested that the aggression was antagonized by the activ-
ity of acetylcholine and serotonin and possibly facilitated 
by norepinephrine. In addition, it suggested that morphine 
and haloperidol produce an anti-aggression action by differ-
ent mechanisms, possibly involving a cholinergic component in 
the case of haloperidol. Finally, the research provided evi-
dence that the dopaminergic supersensitivity following chronic 
treatment with morphine may be qualitatively or quantitatively 
different from the supersensitivity following chronic treat-
ment with haloperidol, since spontaneous and amphetamine-
stimulated aggression are noted only in the former case. It 
was proposed that morphine interferes with cholinergic and/or 
serotonergic compensatory mechanisms and that these contribute 
to t~e aggression. 
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I. INTRODUCTION 
Drugs are capable of producing a variety of behavioral 
changes in laboratory animals. Under the appropriate condi-
tions, drugs can elicit aggressive behavior. Over the past 
several years, aggression has been reported after the admin-
istration of several different types of drugs, most notablyr 
apomorphine (Senault, 1970) and amphetamine (Chance, 1948). 
In addition, aggression has been reported during narcotic 
withdrawal (Boshka ~al., 1966; Lal et al., 1971), which 
is intensified by treatment with either apomorphine or 
amphetamine (Puri and Lal, 1973a). 
The mechanism underlying drug-induced aggression is 
not well established. Apomorphine is believed to directly 
stimulate dopamine receptors in the brain (Ernst, 1967; 
Anden ~al., 1967). Amphetamine is believed to release 
both norepinephrine (Carlsson~ al., 1966; Carr and Moore, 
1969) and dopamine (Besson~ al., 1971; Chiueh and Moore, 
1973), but its behavioral effects are generally regarded as 
the result of dopaminergic stimulation (Van Rossum and Hurk-
mans, 1964; Costa~ al., 1972; Thornburg and Moore, 1973a). 
Therefore, a working hypothesis may be formulated which states 
1 
2 
that a hyperstimulation of dopamine neuronal systems may 
be responsible for aggression. A study of the types of 
drugs which both increase and decrease the degree of ag-
gression may provide some insight into the mechanisms in-
volved in this type of behavior and a method for comparing 
different types of drugs. 
Haloperidol and morphine share a number of behavioral 
effects (see Lal~ al., 1975a) ·, including an anti-aggres-
sive action in fighting elicited by shock (Lal et al., 
1975a), DOPA+ amphetamine (Lal~ al., 1972b) or morphine 
withdrawal (Puri and Lal, 1973a). The two drugs also 
both produce an acceleration of dopamine turnover (Puri 
~al., 1973). 
the two drugs. 
Yet, there are obvious differences between 
Dopamine's behavioral effects are modulated by acti-
vity of other neurotransmitters. For instance, amphetamine 
induced stereotypy is decreased by cholinergic (Arnfred 
and Randrup, 1968) or serotonergic (Weiner ~ al., 1973) 
activity. These types of interactions are rarely studied 
in drug-induced aggression. 
The objectives of this research, therefore, are three-
fold. First, the research will examine the role of brain 
dopamine indrug-induced aggression. Secondly, it will 
investigate the interaction between dopamine and acetyl-
choline and serotonin in this behavior, and thirdly, it 
will compare and contrast haloperidol and morphine after 
both acute and chronic treatment. 
3 
The significance of this research is manifold. The 
primary significance will be the determination of the role 
of brain dopamine in the expression of drug-induced aggres-
sion. 
Secondly, this research will provide information rel-
evant to the interaction between dopamine and acetylcholine 
and serotonin in the CNS, especially in the control of 
drug-induced aggression. 
Thirdly, this research will examine similarities and 
differences between morphine and haloperidol after both 
acute and chronic treatment. Since only the former pro-
duces physical dependence (though both share ~any behav-
ioral actions, see above), this research may provide in-
formation relevant to drug addiction. 
Lastly, this research may have practical significance 
by serving as a potential model for schizophrenia research. 
It has been suggested that schizophrenia may be due to a 
hyperactivity of dopamine neuronal systems in the CNS 
(Klawans ~al., 1972a; Matthysse, 1973). It is proposed 
here, that a similar hyperactivity may be the cause un-
derlying the drug-induced aggression in rodents. If so, 
the drug-induced aggression may serve as a useful tool for 
studying brain changes which may be related ~o schizophrenia 
and serve as a test for screening new potential therapeutic 
agents. 
II. LITERATURE SURVEY 
A. AGGRESSION 
1) General Aspects 
Violence is a well recognized component of human 
society. However, fighting is not restricted to hum-
ans, but is found in a wide variety of animals. Because 
of the ubiquity of this behavior, it has long . attracted 
the attention of psychologists, psychiatrists, ethologists, 
sociologists and other investigators in the behavioral 
sciences. In recent years, it has also been studied by 
pharmacologists who have used aggression to provide 
information on the complex workings of the brain, to gain 
insight into the actions of centrally acting drugs and to 
attempt to rationally develop drugs for the treatment of 
psychopathological disorders. 
Aggression has been defined by Lorenz (1966) as 
"the fighting instinct in beast and man which is directed 
against members of the same species." This behavior, in 
the view of Valzelli (1967), is directed towards removing 
or overcoming what is menacing the physical or psychologi-
4 
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cal integrity of the organism. Aggression is such a wide-
spread phenomenon, that Scott (1958) concluded that it is 
not an accident of evolution but rather a necessary and 
useful part of an animal's life. Aggression is necessary, 
Lorenz (1966) concluded, to establish territoriality, for 
the selection of the strongest member of a species, and 
for the defense of the young. 
Collias (1944) investigated the role of aggression in 
the ecological pattern of living systems and observed that 
a great deal of fighting in vertebrates is associated with 
territoriality. In addition, he observed that fighting in 
animal groups tends to become organized into social domin-
ance hierarchies which has the net effect of greatly redu-
cing the amount of fighting and that one of the major phys-
iological factors connected with fighting in vertebrates 
is the male sex hormone. 
Considerable attention has been focused on further 
delineating the variables underlying aggressive behavior. 
The physiological mechanisms responsible for aggression 
are very complex and involve interactions between neural, 
hormonal and sensory factors, as well as equally complex 
psychological factors. For example, it is believed that 
aggression is strongly stimulus bound. As an illustra-
tion, it is known that rats will kill mice, but not rat 
pups; male mice will attack other males, but will not 
attack females; attacks precipitated by stimulation of the 
6 
hypothalamus of the cat will be directed at a live rat, but 
not at a stuffed rat (see Moyer, 1968). Furthermore, it is 
well recognized that animals respond to postures of their 
opponents which results in inhibition of aggression. In 
addition, other psychological factors such as success at 
fighting influence aggression. Successful, experienced 
animals are much more likely to fight than inexperienced 
ones or animals which have lost a battle (Scott, 1962). 
Thus it is clear that aggression is an extremely complex 
behavior and any hypothesis which purports to explain ag-
gressive behavior would have to be equally complex. 
Moyer (1968) has classified aggression i~to seven 
categories. These are predatory, inter-male, fear-induced, 
irritable, territorial defense, maternal and instrumental. 
These types of aggression were differentiated on the basis 
of stimulus situations which elicit the behavior. Moyer 
~ointed out that different neuroanatomical loci, neural 
mechanisms and topographical patterns may accompany the 
different types of aggression, so that a global explana-
tion encompassing all types of aggression may be an insur-
mountable task. Therefore, it is not surprising that a 
drug may affect different types of aggression in different 
ways. Some of these methods used to study tpe effects of 
drugs on aggression are presented in the next section. 
7 
2) Models of Aggression 
There is a startling variety of methods by which ag-
gression may be studied in the laboratory. The most widely 
used procedures are aggression produced by a painful stim-
ulation (Tedeschi~ al., 1959; Ulrich and Azrin, 1962), 
prolonged social isolation of mice (Yen ~ al., 1959) or 
the administration of drugs. Some other frequently utili-
zed models for the study of aggression include mouse kill-
ing (muricide) by rats (Karli, 1956); frog killing (rana-
cide) by rats (Bernstein and Moyer, 1970); hyperemotionality 
induced by lesions of the septum (Brady and Nauta, 1953); 
rage responses following intracerebral injections of chem-
icals (see Myers, 1975); aggression during extinction of 
an operant task (Azrin ~al., 1966); and the introduction 
of a strange rat into the residence of- another (Miczek, 
1974). It is probable that the models each have a diff-
erent physiological basis. The characteristics of the 
most popular models will be briefly described. 
In the isolation paradigm, male mice are housed singly 
for a period of at least three weeks (Yen et al., 1959). 
The aggression occurs spontaneously when the isolated mouse 
is exposed to another mouse. The mice become progressively 
more aggressive with increasing duration of isolation and 
progressively less aggressive as the size of the group in 
which they live increases (Welch and Welch, 1970). The 
isolated mice are more sensitive to the effects of CNS 
8 
stimulants and less sensitive to .the effects of CNS depres-
sants (Lal et al., 1972a). This type of aggression has been 
extensively utilized for the testing of drugs and is blocked 
by a wide variety of pharmacological substances (Janssen ~ 
al., 1960; Valzelli, 1967) apparently with little selecti-
vity. The isolation report~dly produces a decrease in the 
turnover of brain serotonin and norepinephrine and an in-
crease in the turnover of brain dopamine (Valzelli, 1970). 
In pain-induced aggression, two animals are enclosed 
in an area from which they cannot escape and a painful 
stimulus, usually an electric shock, is delivered to the 
animals. The aggression occurs in females a~ well as males, 
but is not directed towards inanimate objects in the case 
of rats (Ulrich and Azrin, 1962). This procedure has also 
been used for screening drugs (Tedeschi et al., 1959). 
Pain-induced aggression appears to be primarily related to 
the activity of brain catecholamines, especially norep-
inephrine (Eichelman, 1973). 
Pharmacological investigation of aggression may also 
be carried out in fighting that occurs as a result of the 
prior administration of a drug. Several types of drugs are 
capable of producing aggression in laboratory animals, es-
pecially apomorphine (Senault, 1970) and amphetamines (Lal 
~al., 1970; Hasselager ~al., 1972). Aggression also 
occurs during withdrawal following chronic treatment with 
narcotics (Boshka ~al., 1966; Lal~ al., 1971). The 
apomorphine-induced and morphine withdrawal aggression 
9 
will be treated more fully below. The drug-induced aggres-
sion paradigm appears to be related to dopaminergic activity 
in the CNS 
a) Apomorphine-Induced Aggression- Large doses of apomor-
phine, a dopamine receptor agonist (Anden ~al., 1967), 
produce aggression in rats (Senault, 1970; McKenzie, 1971). 
The aggression is directed only towards a similarly treated 
rat and is not observed when a non-treated rat or a mouse 
is put into contact with an apomorphine treated rat (McKen-
zie, 1971). The aggression occurs with increased frequency 
in older (84 day old) rats and is absent in rats less than 
49 days of age (McKenzie, 1971). 
This effect is seen only in male rats (McKenzie, 1971). 
Castration or hypophysectomy decreases, while large doses 
of testosterone increase the degree of aggression (Senault, 
1972). 
When lesions are made in the amygdala or the substan-
tia nigra of rats, apomorphine-induced aggression is re-
duced. In contrast, lesions which destroy the septum or 
olfactory bulb enhance the degree of aggression but fail 
to produce aggression in normally non-aggressive rats 
(Senault, 1973). 
The effect of various drugs on apomorphine-induced 
aggression have been studied. Neuroleptics and anxiolytics 
reduce the degreee of aggression (Senault, 1970} as do 
the alpha-adrenergic blocker, phenoxybenzamine (Senault, 
1974); the beta-adrenerg i c blocker, propranolol (Butter-
10 
worth~ al., 1975); and the anticholinergic, atropine 
(Senault, 1970; Dlabac, 1973). A slight decrease in the 
aggression is produced by 5-~ydroxytryptophan (Senault, 
1974). The aggression is increased by L-DOPA, MAO in-
hibitors (Senault, 1974), reserpine (McKenzie, 197l) and 
to some extent by clonidine (Senault, 1974; Butterworth~ 
al., 1975). A sensitization to the effect of apomorphine 
has been shown following withdrawal from narcotics (Puri 
and Lal, 1973a) or treatment with 6-hydroxydopamine 
(Eichelman and Thoa, 1973). It has been reported that 
little if any effect on apomo~phine-induced aggression 
is produced by antidepressants (Dlabac, 1973), PCPA or 
alpha-m-dopa (Senault, 1974). 
Lastly, it has been noted that ET-495, another drug 
believed to stimulate dopamine receptors (Corrodi ~ al., 
1972) also produces aggression (Senault, 1974). 
b) Morphine Withdrawal Aggression - Rats can be made de-
pendent on narcotics and will exhibit a number of behav-
ioral changes during withdrawal from these drugs (Martin 
et al., 1963). Dependent rats undergoing withdrawal from 
morphine are hyperirritable and, when placed together, will 
show vigorous fighting (Boshka et al., 1966). The aggress-
ion is blocked by continued treatment with morphine, but 
emerges when drug administration is discontinued. The 
aggression reaches its maximum approximately three days 
after withdrawal has been initiated (Thor et al., 1970; 
Puri and Lal, 1973a). The fighting consists of vocaliza-
11 
tions, aggressive postures, biting and other forms of attack 
and often leads to severe injury or death of some of the 
rats (Lal, 1975). Abstinence from other narcotics, such 
as etonitazene ( F lorea and Thor, 1968), methadone (Singh, 
1973) or fentanyl (Lal~ al., 1975b) also results in with-
drawal aggression, but spontaneous aggression is not noted 
after chronic treatment with amphetamine, alcohol or barbi-
turates (Pu~i and Lal, 1974b)~ Morphine withdrawal aggres-
sion has also been reported in mice (Weissman, 1973) and 
guinea pigs (Goldstein and Schulz, 1973). Rage and diffi- . 
culty in handling has also been reported during narcotic 
withdrawal in monkeys (Seevers and Deneau, 1963). 
The aggression differs from natural aggression in that 
posturing by the subordinate animal which usually leads to 
cessation of aggression, does not inhibit fighting during 
withdrawal, and a withdrawn rat will attack a dead rat 
(Crabtree and Moyer, 1973). Some aggression, although to 
a lesser degree, is shown by females in morphine withdrawal 
(Crabtree and Moyer, 1973). Older rats are more responsive 
than younger ones (Davis and Khalsa, 1971). 
The aggression occurs spontaneously during withdrawal 
but can be markedly increased by directly (Puri and Lal, 
1973a) or indirectly (Thor, 1969; Lal~ al., 1971) acting 
dopamine receptor stimulants. These observations first 
suggested that dopamine supersensitivity develops during 
narcotic addiction (Puri and Lal, 1973a). Small doses of 
d- or 1-amphetamine potentiate the aggression and are near-
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ly equipotent in this regard (Lal !U_ al., 1971). Hydroxy-
amphetamine, which has only a peripheral action, does not 
en~ance the aggression (Lal et al., 1971). Similarly, the 
aggression is markedly enhanced by small doses of apomor-
phine or L-DOPA and is decreased by dopamine receptor block-
ade by haloperidol or by inhibition of dopamine synthesis 
by alpha-methyl-p-tyrosine (Puri and Lal, 1973a). Apomor-
phine also induces aggression in morphine dependent mice 
(Iorio~ al., 1975). These results strongly suggest the 
involvement of brain dopamine in morphine addiction and 
withdrawal. In addition, morphine withdrawal aggression 
is also enhanced by extracts of Cannabis sativa (Carlini 
and Gonzalez, 1972). 
B. DOPAMINE IN THE CENTRAL NERVOUS SYSTEM 
1) Dopamine Pathways 
Dopamine, like other central neurotransmitters, has 
an uneven distribution in the CNS. The discovery of high 
levels of dopamine in the basal ganglia by Bertler and 
Rosengren (1959) gave rise to the idea that dopamine has a 
function of its own, independent of being a precursor of 
norepinephrine. Dopamine is distributed in the basal 
ganglia, the limbic system, the hypothalamu~ and the cortex. 
The existence of dopamine fiber pathways in the CNS has 
been demonstrated through studies employing lesions, stimu-
lating electrodes, biochemical and histochemical techniques. 
Based upon these studies, the following dopaminergic path-
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ways have been described: 
a) Nigro-neostriatal Dopamine neurons 
b) Mesolimbic Dopamine neurons 
c) Tubero-infundibular Dopamine neurons 
a) Nigro-Neostriatal Dopamine Neurons - The nigro-neostri-
atal system seems to originate mainly in the pars compacta 
of the substantia nigra (Anden et al., 1964). Support for 
this comes from fluoTescence microscopy and the high dopa-
mine content observed in this area (Hornykiewicz, 1966). 
Unilateral pars compacta lesions result in a 60 per cent 
lowering of the dopamine level in the corpus striatum of 
the operated side when compared with the unoperated side 
(Faull and Laverty, 1969). The caudate nucleus and put-
amen show a fairly strong green to yellow fluorescence 
due to the high dopamine content. This fluorescence was 
reduced in animals with lesions of the- substantia nigra. 
A clear correlation was found between the fluorescence 
reduction and the extent of destruction of the pars com-
pacta (Anden il_ al·, 1964). Some cell bodies are also 
found in the zona reticulata and the pars lateralis of 
the substantia nigra, which also belong to the nigro-
neostriatal dopamine system (Fuxe et al., 1970). Recent-
ly, studies after the removal of the nucleus caudatus 
putamen suggest that the cell bodies of the ventrolateral 
part of the midbrain tegmentum belong to this uncrossed 
neuron system, in as much as they show marked reduction in 
fluorescence intensity and signs of atrophy after such 
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operations (Fuxe et al., 1970). There is now a virtually 
complete picture of the distribution of these dopamine 
fibers. Upon leaving the pars compacta of the substantia 
nigra, most of the nigro-neostriatal dopamine fibers become 
aggregated in a bundle which ascends just medially and 
dorso-medial to the ventral part of the crus cerebri. At 
the level of the posterior part of the median eminence, 
the bundle turns to the ventrolateral part of the crus cere-
bri and enters and diverges into the retrolenticular part 
of the internal capsule. Running rostrally and dorsally in 
the internal capsule, the fibers then ascend in the fibers 
of the internal capsule to innervate the neostriatum (An-
den et al., 1965). 
Biochemical and histochemical investigations have 
yielded some quantitative data on the unilateral nigro-
neostriatal dopamine system in the rat. The number of 
neurons making up this system is 3500 on the average. 
There are about 1.2 X lo-lO grams of dopamine per neuron 
w1th terminals containing 50 times more dopamine than the 
cell bodies. There are approximately 500,000 varicosities 
in the terminals, each with an average diameter of 0.4u, 
containing 2.5 X lo-16 grams of dopamine and has a dopa-
mine concentration of around 8000 ug/gr wet weight. One 
dopamine cell body of the substantia nigra, with a mean 
diameter of 30u, contains 2.5 X lo-18 grams and has a 
dopamine concentration of from 60 to 200 ug/gr (Anden et 
~~, 1966d). 
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These data imply that dopamine is a neurotransmitter 
of the nigro-neostriatal pathway. There is evidence to 
indicate that dopamine may function as an inhibitory neuro-
transmitter at the terminals of the nigro-striatal path-
way. Bloom and coworkers (1965) demonstrated that dopa-
mine has primarily an inhibitory action when applied micro-
iontophoretically to caudate neurons. Most of the neurons 
that respond to dopamine are inhibited by exogenous dopa-
mine applied to the caudate nucleus of anesthetized and 
decerebrated cats (McLellan and York, 1967; York, 1970). 
Following the application of dopamine iontophoretically 
from multibarrel micropippettes near caudate cells, the 
rate of discharge of 50 to 60 per cent of these neurons 
is depressed, while the spike rate of approximately 10 
per cent of the cells is facillitated. Electrical stimu-
lation of the substantia nigra evokes depressant and 
facillatory responses from individually recorded caudate 
neurons (Connor, 1968; 1970). 
b) Meso Limbic Dopamine Neurons - The mesolimbic dopamine 
neurons have their cell bodies in the area surrounding the 
nucleus interpeduncularis and fibers from these cell bod-
ies terminate in the tuberculum olfactorium, nucleus ac-
cumbens, the dorsolateral part of the nucleus intersti-
tiata striae terminalis and in the nucleus amygdaloideus 
centralis (Anden et al., 1966b). These areas have been 
shown to contain large quantities of dopamine which is 
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not associated with norepinephrine synthesis (Koslow et 
al., 1974}. A dopamine ~ensitive adenylate cyclase has 
als·o lie en found :i:n tlie tuoerculum o 1 facto rium, nucleus 
accumoens and amygdala (C l ement-Cormier il al., 1974). 
These cyclase systems are considered to resemble the 
"dopamine receptor" (Kebabian et al., 1972). Dopamin-
ergic fibers of this system run medially to the nigro-
striatal dopamine fibers, wheras cranially they lie 
mainly ventral 
al., 1966b). 
to the nigro-striatal syste~ (Anden et 
The mesolimbic dopamine neurons probably contain 
less dopamine than do nigro-striatal neurons. This is 
probably because the terminal network of each meso-
limbic neuron is much smaller than that of the nigro-
neostriatal dopamine neurons (Anden il al., 1966c; Fuxe 
il al., 1970). 
c) Tubero-Infundibular Dopamine Neurons - The tubero-
infundibular dopamine neurons have their cell bodies 
mainly localized in the anterior part of the nucleus 
annuatus and anterior periventricular nuclei. The axons 
of this system run ventrally toward the lateral border of 
the median eminence (Fuxe, 1963; Fuxe and Hokfelt, 1966; 
1969). In the external layer of the median eminence, the 
axons give rise to a densely packed plexus 6f dopaminergic 
nerve terminals, which exerts an axo-axonic influence in 
the layer (Hokfelt, 1967). 
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This very short dopaminergic intrahypothalamic system 
regulates the discharge of the releasing and inhibiting 
factors from the median eminence (Fuxe ~al., 1970). The 
release of doapmine in the median eminence acts locally on 
terminals storing luteinizing hormone releasing factor 
(LHRF) to inhibit the release of LHRF from the median emin-
ence. This system also participates in mediating the nega-
tive feedback action of estrogen and testosterone on gonad-
otropic secretion, because estrogen and testosterone mark-
edly increase the turnover of tubero-infundibular dopamine 
in neurons of castrated rats, resulting in increased release 
of dopamine in the area (Fuxe ~ ~., 1967; 1969). The 
blockade of ovulation by synthetic estrogens and their der-
ivatives may at least be partly mediated via activation of 
this neuron system (Fuxe and Hokfelt, 1969). This system 
is also highly sensitive to prolactin, which markedly in-
creases the turnover of dopamine in tubero-infundibular 
neurons (Fuxe and Hokfelt, 1969). 
d} Cortical Dopamine Neurons - In addition to the well 
defined tracts described above, large quantities of dop-
amine have also been found in the cortex of various species 
(Bertler and Rosengren, 1959). It appears that most of the 
dopamine found in the cortex of the rat is not localized 
in noradrenergic terminals. Lesions of the dorsal nor-
adtenergic system or combined lesions of the dorsal and 
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ventral noradrenergic aystems, which both significantly 
decrease cortical levels of norepinephrine, did no~ in-
duce a parallel reduction of cortical dopamine content 
(Thierry~ ·al., 19730). These fingings strongly suggest 
the existence of dopaminergic neurons in the cortex. Fur-
ther evidence for the existence of dopaminergic terminals 
in the rat cortex ~s provided by the fact that cortical 
synaptosomes have the ability to synthesize 3H-dopamine 
from 3H tyrosine (Thierry~ _tl., 1973a). The destruction 
of ascending noradrenergic pathways which abolishes the 
in vitro synthesis of 3H-norepinephrine did not affect the 
synthesis of 3H-dopamine (Thierry~&., 1973a). In 
addition, a specific dopamine reuptake process has been 
demonstrated in the cerebral cortex of normal rats and 
in rats whose ascending noradrenergic pathways have been 
selectively destroyed (Tassin~ al., 1974). The dopamine 
cells in the cortex have recently been visualized by his-
tofluorescence techniques (Hokfelt ~al., 1974). The 
dopamine was shown to be distributed throughout the limbic 
cortex, but was not present in the neocortex (Hokfelt et 
al . , 19 7 4) • Part of the dopamine terminals in the cortex 
originate in the A9 and AlO areas of the substantia nigra 
(Lindvall and Bjorklund, 1974). A dopamine-sensitive aden-
ylate cyclase has also been found in the cortex (Von Hun-
gen and Roberts, 1273}. 
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2) Dopamine Release and Turnover,in the CNS 
Using a push-pull cannula, McLennan (1964) demon-
strated the resting release of dopamine from the caudate 
nucleus, which was estimated to occur at the rate of lng/min. 
Electrical stimulation of the substantia nigra produced an 
increase in dopamine outpu~ in the putamen ('McLennan, 1965) 
and an increase in dopamine and its metabolite, homovanil-
lic acid (HVA) in the lateral ventricle of the cat (Portig 
and Vogt, 1969). A frequency and intensity related release 
of labelled dopamine from the caudate nucleus was also dem-
onstrated after stimulation of the nigro-striatal bundle 
or the caudate (Von Voightlander and Moore, 197la; 197lb). 
Similar results were shown when caudate dopamine stores 
were specifically labelled by radioactive tyrosine {Chiueh 
and Moore, 1973). Electrode placements more medial or 
lateral in the hypothalamus failed to induce dopamine re-
lease (Chiueh and Moore, 1973). These results clearly im-
plicate dopamine as the neurotransmitter in the nigro-
striatal pathway. 
The release of dopamine can be further enhanced by 
potassium or by drugs such as amphetamine (Besson~ al., 
1971). The amphetamine induced release is prevented by 
lesions of the nigro-striatal bundle (Von Voightlander 
and Moore, 1973a}. 
Lesioning of the nigro-striatal bundle produces a 
gradual degeneration of dopamine terminals and a marked 
·reduction of dopamine levels in the striatum (Poirer and 
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Sourkes, 1965; }loore··ll ·a1., 1971; Oltsman and Harvey, 
1972). However, inhibition of the firing of the nigro-
striatal bundle by lesions or administration of gamma-
hydroxybutyrate causes an immediate increase in the levels 
of caudate dopamine (Walters et al., 1973). 
--
The effect of drugs on the release and utilization of 
brain dopamine is usually indirectly determined after assess-
ing the drug's effect on dopamine turnover. The turnover 
of dopamine refers to the overall rate at which the dopa-
mine stores are replaced in a given tissue. The turnover 
of rat brain dopamine has been estimated to occur at the 
rate of 0.21 ug/g/hr, with a turnover time of 3.6 hours 
(Neff and Costa, 1966). The turnover rate can be influenced 
by a variety of physiological situations and can also be 
affected by drugs (see section B.4). The overall rate of 
catecholamine formation is governed by the activity of 
tyrosine hydroxylase (Levitt~ al., 1965), the first 
enzyme in the synthetic pathway. The synthesis of new 
dopamine is regulated by a complex process involving 
end-product inhibition (Udenfriend gal., 1959); activity 
of post-synaptic receptors (Carlsson and Lindqvist, 1963); 
activity of pre-synaptic autoreceptors (Roth g ·al., 1975); 
and brain tyrosine concentrations (Wurtman gal., 1974). 
Drugs may interact at any potnt, but drug effects are gen-
erally considered to occur oy increasing or decreasing 
dopamine receptor stimulation. In general, a drug which 
!µcreases dopamine receptor activity would decrease dopa-
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mine turnover, while a d~ug that decreases dopamine recep-
tor ac ti:v:t ty· would increase dopamine turnover. 
31 Rehavioral Effects of Dopamine 
Activ::tty of dopa-minergic neurons in the CNS is respon-
sible for the regulation of numerous behaviors. These in-
elude motor effects (catalepsy, Parkinsonism, locomotor ac-
tivity); reward mechanisms (self-administration, self-stim-
ulation); consummatory behaviors; and bizarre behaviors 
(stereotypy, aggression, schizophrenia). 
will be briefly described. 
These effects 
a) Motor Functions - The degeneration of the nigro-stri-
atal pathway causes the motor dysfunctions associated with 
Parkinson's Disease (Hornykiewicz, 1966). This degeneration 
leads to akinesia, rigidity and tremors in human patients. 
It is possible to restore normal motor function in Parkin-
sonian patients by treatment with L-DOPA (Cotzias et .2J:.., 
1967) which markedly elevates the level of brain dopamine 
(Everett and Borcherding, 1971). In animals, the defi-
ciency of striatal dopamine leads to an immobility termed 
catalepsy. This can be accomplished by large lesions of 
the mesencephalic-diencephalic areas of the brain which 
disrupt dopamine activity in the neostriatum (Anden ~al., 
1966e) . or by the administration of neuroleptic drugs 
either systemically (Janssen· ~ al., 1965) or directly 
into the caudate-putamen or globus pallidus (Costa11· et 
al., 1972). 
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Unilateral lesions o~ the nigro-striatal pathway or 
the corpus striatum are known to produce asymmetries in 
movement and posture (Poirer and Sourkes, 1965; Anden et 
al., 19660}. The difference oetween the two sides of the 
brai.n may Be fur ther aggravat ed by treatment with drugs 
that release dopamine from the non-lesioned side. Such 
animals show a pronounced rotational behavior (Anden ~ 
al. , 19'6 6b) • The rotational behavior is further linked 
to the differences in dopamine levels on the tw~ sides of 
the _ brain by the finding that unilateral striatal injec-
tions of dopamine causes the rats to turn or slowly rotate 
away from the side where dopamine was injected (Unger-
stedt ,et al., 1969). Spontaneous rotations towards the 
intact side are seen 24 to 34 hours after a lesion of the 
nigro-striatal dopamine system. The direction of the 
rotation as well as the time point of its occurence is 
indicative of a degeneration release of dopamine from the 
lesioned side (Ungerstedt, 197la). In a chronically 
lesioned animal, there is a striking difference between the 
effects of dopamine-releasing drugs and dopamine receptor-
stimulating drugs. Amphetamine causes the animal to ro-
tate towards the lesioned side, apomorphine causes it to 
rotate towards the intact side (Ungerstedt, 197la). 
rntrastriatal injections of dopamine produce motor 
hyperactivity in rats (Benkert and Kohler, 1972). Sim-
ilarly, large doses of L~DO~A combined with a peripheral 
aromatic acid decarooxylase inhibitor produce an increase 
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in spontaneous locomotor activity which is associated with 
a seven-fold increase in orain dopamine levels, while nor-
epinephrine remains unchanged (Butcher et al., 1972). 
rn addition, the locomotor stimulation produced by 
amphetamine is believed to be due to release of dopamine 
(Van Rossum and Hurkmans, 1964; Thornburg and Moore, 
1973a; Hollister~ al., 1974). Depletion of brain nor-
epinephrine by inhibition of dopamine-beta-hydroxylase 
(Thornburg and Moore, 1973a) or treatment with 6-hydroxy-
dopamine (Hollister ~ !:!.1·, 1974) failed to alter the 
amphetamine-induced stimulation, while selective dopamine 
depletion did reduce the amphetamine effect. 
b) Reward Mechanisms - Reward systems are usually thought 
of as being noradrenergic (Stein, 1968), but recent evidence 
has suggested a major role for dopamine as well. In addi-
tiort to the traditional sites of electrode placement, 
self-stimulation behavior may also be maintained from 
electrodes placed in the substantia nigra (Arbuthnott et 
.i!!.•, 1970) or the nucleus accumbens (Phillips et al., ]975), 
both of which are important dopaminergic sites. Self-stim-
ulation from the lateral hypothalamus is blocked by the 
dopamine receptor blockers, haloperidol and pimozide 
(Wauquier and Niemegeers, 1972; Lippa~ al., 1973), but 
not by phentolamine, a noradrenergic receptor blocker, or 
oy the inhibition of norepinephrine synthesis with FLA-63 
(Lippa· ·et al. , 19 7 3) . Furthermore, dep le ti on of dopamine 
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by 6-hrdroxydopamine depressed brain self-stimulation, 
wh:tle s:tm:tlar treatment:;;: which deplete norepinephrine were 
ineffect :tve (Cooper ·g ·al., 1974). The action of amp he ta-
mine in enhancing self-stimulation was similarly affected 
oy 6-hydroxydopa1lline treatment (Cooper il al., 1974}. 
Lastly, it was shown that d- and 1- amphetamine were equi-
potent in enhancing self-stimulation from dopaminergic 
sites while d-amphetamine was more potent in noradrenergic 
sites (Phillips and Pibiger, 1973; Phillips et ·al., 1975). 
--
These differences in potencies closely parallelled the in 
vitro effect of amphetamine in releasing norepinephrine 
or dopamine (Azzaro and Rutledge, 1973). 
In addition, the self-administration of amphetamine 
is apparently dependent on dopaminergic mechanisms since 
low doses of dopamine receptor blockers selectively increase 
lever pressi~g for amphetamine (analagous to the effect seen 
after decreasing the dose of amphetamine in the self-admin-
istered solution), while higher doses produce extinction 
(Yokel and Wise, 1975). Lastly, apomorphine, a direct . 
dopamine agonist, is also self-administered by rats (Bax-
ter il al., 1974). 
c) Consummatory Behavior - Aphagia ~nd adipsia result from 
the destruction of dopamine fibers coursing through the 
lateral hypothalamus by electrolytic lesions or 6-hydroxy-
dopamine treatment (Ungerstedt, 197lb). This behavior is 
correlated with biochemical and histochemical evidence of 
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decreased dopaminergic input to the striatum (Ungerstedt, 
19710; Zigmond and Stricker, lg72; Glick et' ·al., 1974; 
Hynes~ .2.1·, lg75). Similar destruction of noradrenergic 
fiBers failed to produce these deficits in eating and 
drinking (Ungerstedt, 19710). 
d) Bizarre Behaviors - Injections of drugs which increase 
brain dopaminergic · activity, such as apomorphine, DOPA or 
amphetamine, result in a compulsive gnawing behavior 
(Harnack, 1874; Randrup and Udsen, 1963; Ernst, 1965) 
termed stereotypy. This behavior consists of repetitive 
sniffing, licking and chewing of the cage. This behavior 
is also noted after direct injection of apomorphine into 
the striatum (Smelik and Ernst, 1966) or the olfactory 
tubercles (McKenzie, 1972). 
Various dopaminergic structures h~ve been reported 
to be the site responsible for stereotypy on the basis 
of studies involving lesions and local injections. These 
include the striatum (Smelik and Ernst, 1966; Fog ~al., 
1970; Ungerstedt ~al., 1969); the olfactory tubercles 
(McKenzie, 1972); and various other portions of the meso-
limbic dopamine system (Costall and Naylor, 1973). 
It is interesting to note that recent theories con-
cerning the etiology of schizophrenia have suggested that 
it is t~e result of dopaminergic hyperactivity in the 
striatum (Klawans il ·al., 19'72a); the limbic system 
(Matthysse, 1973); or the cortex (Hokfelt ~ ·.2.1., 1974). 
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The blockade of stereotypy has be~n used as a screening 
procedure ~or detecting anti-p$ychotic actiy t t~ of drugs 
(Janssen ·et al., 1~651. 
--
The hypothesis put forward in this thesis is that drug-
induced aggression is also tlie result of dopaminergic hyper-
activity. Apomorphine and amphetamine generally produce 
aggression in rats and ~ice, respectively (see Section II. 
A.2). Apomorphine is believed to directly stimulate dopa-
mine receptors (Anden ~al., 1967), while amphetamine re-
lea~es dopamine (Besson~~., 1971). ET-495, another 
dopamine receptor stimulant (Corrodi ~al., 1972a), also 
produces aggression in rats (Senault, 1974). Similarly, 
DOPA administration results in a substantial increase in 
brain dopamine and elicits fighting, while similar treat-
ments which raise norepinephrine are ineffective in pro-
ducing fighting (Benkert~ al., 1973a). A more detailed 
discussion of the relevant data is found in Section V. 
4) Effects of Drugs on Dopamine Levels and Turnover 
This research is primarily concerned with the actions 
of apomorphine, haloperidol and morphine. All of these 
drugs have profound effects on brain dopamine, which are 
important in the determination of their mechanisms of 
action. These effects will be examined in this section 
a} Apomorphine - Apomorphine is believed to d~rectly stim-
ulate dopamine receptors. This conclusion is based on Be-
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havioral e.xperlments in wh_ich apomorphine-induced stereo-
typy was unaffected oy· depletion of dopamine oy alph.a-
methyl-p-tyros ine ('MPT) CErns-t, 1967) or By 6-hydroxydopa-
mine lesions of the suBstantia nigra (Price and Pibiger, 
1974). These treatments aoolished the stereotypy produced 
oy amphetamine (Ernst, 1967; ~rice and Pibiger, 1974), 
which is Believed to release dopamine from pre-synaptic 
terminals (Besson ·et al., 1971; Chiueh arid Moore, 1973). 
Neurochemically, apomcrrphine decreases the turnover of 
striatal dopamine. The drug decreases the incorporation 
of cl4 tyrosine into cl4 dopamine (Persson, 1970; Nyback 
etal., 1970), decreases the disappearance of dopamine 
after MPT administration (Anden ~al., 1967; Puri~ al., 
1973), decreases the rate -of formation of homovanillic 
acid (Roos, 1969) and decreases the accumulation of DOPA 
after decarboxylase inhibition by NSD 1025 (Koe, 1974). 
These biochemical changes are blocked by prior adminis-
tration of neuroleptics (Anden ~al., 1967; Anden and 
Bedard, 1971; Lahti et al., 1972). Recently, apomorphine 
was also shown to decrease the turnover of dopamine in 
cortical areas (Scatton~ al., 1975). 
In experiments where histofluorescence was measured, 
apomorphine retarded the reduction in dopamine fluoresc-
ence which normally occurs after MPT (Anden ~ ·al., 1967}. 
Small doses of apomorphine also depress the firing rate 
of dopamine cells (Bunney 'et ·al., 1973a), presumably oy 
a . feedback mechanism. These effects are likewise blocked 
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by haloperidol while the effects on firing rate are un-
affected DY' X:eT. 
These results ha~e Been interpreted as d~e to a de-
crease in activity of dopamine neurons as a compensatory 
mechanismsfor receptor stimulation by the apomorphine 
(Anden il al., 1967; Lahti ·et al., 1972; Puri· il al., 
1973). Although apo~orphine can inhibit tyrosine hydro-
xylase (Goldstein et al., 1970), the doses required ·in 
vitro are substantially higher than necessary to produce 
functional changes. 
b) Haloperidol - Haloperidol, and related anti-psychotic 
drugs, are believed to block dopamine receptors. The Be-
havioral consequences of this effect are the induction of 
catalepsy, ptosis and inhibition of operant avoidance and 
brain self-stimulation (Fielding and Lal, 1974). 
Neurochemically, haloperidol increases the turnover 
of dopamine in the striatum (Anden et al., 1970a), the 
meso-limbic areas (Anden il al., 1970a) and the cortex 
(Scatton il al., 1975). This is accomplished without al-
tering the levels of dopamine in the brain (Anden et al., 
1966a). There is also no change in brain dopamine levels 
after chronic haloperidol treatment (Gyorgy et al., 1969; 
Puri and Lal, 1974a; Hyttel, 1974). Tolerance to the 
dopamine turnover enhancing effect of haloperidol has been 
reported after chronic treat1!lent (Asper ·il al., 1973), 
but Puri and Lal (1974a) failed to observe this phenomen-
on, although they did find that morphine dependent rats 
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were tolerant to the effects of haloperidol. Haloperidol 
increases the srnthesis of labelled dopamine from radio-
active tyrosine (Nyback et al., 1970}, increases th.e de-
pletion of brain dopamine after the administration of 
MPT (Neff and Costa, 1966; Corrodi il ~., 1967), in-
creases the rate of accumulation of the dopamine meta-
bolites, homovanillic acid and 3,4-dihydroxyphenylacetic 
acid (Anden il -~., 1966a; Roos, 1965) and 3-methoxytyr-
amine and normetanephrine (after MAO blockade) (Carlsson 
and .Lindqvist, 1963} and increases the accumulation of 
DOPA after NSD 1025 (Cegrell et al., 1970). The halo-
peridol induced increase in dopamine depletion follo-
w~ng MfT requires intact nigro-striatal fibers for the 
effect to occur (Anden il al., 1971). In addition, halo-
peridol reduces the stimulation of adenyl cyclase caused 
by dopamine (Clement-Cormier et al., 1974) and increases 
the firing rate of dopamine cells (Bunney il al., 1973b). 
The interpretation of these results has been that 
haloperidol blocks dopamine receptors and this causes a 
compensatory activation of dopamine neurons to increase 
the concentration of dopamine in the synaptic cleft 
(Caxlsson and Lindqvist, 1963). However, haloperidol 
failed to alter the in vi·vo efflux of labelled dopamine 
into the ventricle of the cat (Von Voightlander and 
Moore, 1973b}. I;t has· also oeen proposed that halo-
peridol may block the pre-synaptic coupling between 
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nerve impulses and transmitter release (Seeman and Lee, 
1975}. Recent evidence suggests that the increased firing 
of the dopamine neuron produced oy the neuroleptics en-
hances the affinity of tyrosine hydroxylase for its pteri~ 
dine co fa c to r ( Z iv k..o vi c ·g ·.!!.!_. , 1 9 7 4 ) • 
c) Morphine - Morph~ne is also believed to decrease the 
effect of dopamine in the CNS. Morphine does not alter 
the steady state level of dopamine in the rat (Gunne: il 
a 1 • , 1 9 6 9 ; Puri il a 1. , 1 9 7 3 ) or c at (Moo re il a 1 . , 1 9 6 5 ) , 
although a transient increase in dopamine levels occuring 
at two and four hours after drug administration has been 
reported in the rat (Clouet and Ratner, 1970). Morphine 
causes a decrease in dopamine levels in the mouse (Takagi 
and Nakama, 1966; Rethy ~ al., 1971) and an increase in 
levels in the monkey (Segal il al., 1972). 
The exact relationship between dopamine and narcotic 
drugs may not be defined by the measurements of dopamine 
. 
content of nervous tissue since these reflect only gross 
changes and may not reveal local changes or alterations 
i~ the turnover of dopamine. 
14 Morphine increases the conversion of C tyrosine to 
labelled dopamine in the rat (Clouet and Ratner, 1970; 
Costa~ al., 1973). The c14 dopamine reaches maximum 
concentrations in the striatum one hour after morphine 
administration (Clouet and Ratner, 1970). Morphine also 
increases the turnover of dopamine in the mouse (Smith 
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et al., 1970; Loh il ·a1., 1973), an effect which is blocked 
D°f tfte narcotic ant.agonist nalo.xone (Smith .tl ·.§!.1.., 19721. 
Morphine also causes an increase in the depletion of 
dopamine in the rat orain after inhibition of catecholamine 
synthesis by MPT CGunne ·il al., 1969; Puri et ·al., 1973}. 
This depletion was determined By histofluorescence to occur 
in the dopamine terminals of the striatum, the nucleus 
accumbens and the olfactory tubercles (Gunne ·il .§!.1.., 1969). 
In addition, morphine increases the concentration of the 
dopamine metabolites, homovanillic acid and 3,4-dihydroxy-
phenylacetic acid (Kuschinsky and Hornykiewicz, 1972; 
Fukui and Takagi, 1972; Kuschinsky, 1973). This effect 
is also blocked by naloxone, while the corresponding in-
crease in homovanillic acidproduced by chlorpromazine is 
unaffected by naloxone (Kuschinsky and Hornykiewicz, 1972). 
Lastly, morphine increases cyclic AMP formation by a dopa-
mine sensitive adenylate cyclase (Puri et al., 1975). 
--
The mechanism by which morphine enhances dopamine 
turnover is not well established. Morphine does not alter 
either in vitro (Clouet il .§!.1.., 1973) or in vivo (Cicero 
il al., 1973) tyr9sine hydroxylase, nor does it alter the 
affinity of tyrosine hydroxylase for its cofactor, substrate 
or end product (Cicero et al., 1973). Puri and coworkers 
(1973} proposed that morphine blocks dopamine receptors 
and the increased turnover reflects a compensatory in-
crease in neuronal activity analagous to the effect of 
neuroleptics. Consistent with this hypothesis is the 
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observation that the increased synthesis of new dopamine 
produced by· ~orphine is associated with an increased re-
lease of dopamine into an incubation medium from striatal 
slices (Gauchy- ~ al., 19"73). Methadone lias also been pro-
posed to act via post synaptic dopamine receptor blockade 
(Sasame ~al., 1972J. Alternatively, it has been suggested 
that morphine produces a functional deficiency of dopamine 
by diverting newly synthesized dopamine from storage sites 
to sites of cataoolism (Kuschinsky and Hornykiewicz,1972). 
· After chronic treatment with morphine, there is a 
slight increase in the dopamine content of the brain in 
rats (Sloan~ al., 1963; Johnson et !!.l·• 1974), but dopa-
mine levels remain unchanged after prolonged treatment in 
dogs (Gunne, 1963) or monkeys (Segal~ al., 1972). 
Although most researchers report that a tolerance develops 
to the effect of morphine on brain dopamine turnover 
(Gunne et al., 1969; Smith et al., 1972; Costa et al., 
-- --- ----
1973; Puri and Lal, 1974a), it has also been reported 
that morphine continues to increase the synthesis of dopa-
mine aft er chronic treatment (Johnson~ al., 1974}. This 
effect may be associated with the increase in tyrosine 
hydroxylase activity which reportedly occurs during chronic 
morphine treatment (~eis ~al., 1970). However, de-
creased tyrosine hydroxylase activity has also been re-
ported in rats implanted w·ith morphine pellets (Branchey 
~G· 1974). 
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During morphine withdrawal, brain dopamine was deer-
eased in dogs, 72 hours after w~thdrawal was initiated 
(Gunne, 1963). In rats, Brain dopamine levels appear to 
remain unchanged during with drawal (Maynert and Klingman, 
1962; Puri and Lal, 1974a), although a decrease in levels, 
relative to inflated levels during addiction, has been re-
ported (Sloan et al., 1963). 
--
In contrast to these results, 
which were obtained in animals which were withdrawn by with-
holding of morphine injections, abstinence precipitated by 
naloxone administration reportedly increases the level of 
brain dopamine in rats and mice (Iwamoto il tl•, 1973). 
The turnover of brain dopamine also appears to remain 
unchanged during morphine withdrawal (Puti and Lal, 1974a) 
although decreased dopamine turnover has also been reported 
in rats (Gunne il tl·, 1969) and mice (Rosenman and Smith, 
1972). In addition, caudate tyrosine hydroxylase activity 
is reportedly elevated at 48 hours of withdrawal in rats 
(Reis il al., 1970) and decreased at 36 hours of withdrawal 
in mice (Marshall and Smith, 1974). 
C. DOPAMINE rNTERACTIONS IN TRE CNS 
The effects of dopamine in the CNS are ~o~ulated by 
activity of other Brain neurotransmitters. The comple.xity 
of the brain demanGs that activity in one area will have 
cons e qu enc es in an o th.er are a , s o that i t i s f o o 1 h_a rd y t o 
investigate the actions of one transmitter as if it existed 
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independen tly. These delicate equilibria are important 
aspects of the normal functioning of the brain and drug 
interference wi th the normal balance of transmitter func-
tion may be an essential component of the drug's action. 
The most widely studied of dopamine's interactions are 
with acetylcholine and serotonin. 
1) Acetylcholine 
The concept of an interaction between dopamine (DA) 
and acetylcholine (ACh) developed from the clinical obser-
vations that Parkinsonism could be relieved either by in-
creasing dopamine activity or by decreasing cholinergic 
activity (Klawans, 1968). Subsequently, considerable be-
havioral and neurochemical evidence has been gathered to 
support the idea of a reciprocal balance between ACh and 
DA. 
Catalepsy, which is~produced by drugs which decrease 
dopaminergic activity in the brain, is also produced by 
cholinergic drugs (Costall ~al., 1972), while the neuro-
leptic-induced catalepsy is reversed by anticholinergics 
(Morpurgo and Theobald, 1964). Similarly, the anti-
cholinergics enhance, while cholinergics block, the ster-
eotypy produced by dopamine receptor stimulation (Arnfred 
and Randrup, 1968; Scheel-Kruger, 1970; Klawans ~al., 
1972b). In addition, anticholinergic drugs are reported 
to reverse the neuroleptic-induced blockade of methylphen-
idate stereotypy (Fjalland and Moller-Nielsen, 1974a). 
35 
Likewise, the amphetamine-induced locomotor stimulation 
is enhanced by scopolamine (Fibiger ~ al., 1970) and in-
hibited by tremorine (Mennear, 1965)., while the locomotor 
stimulation produced by anticholinergics is blocked by re-
ducing the synthesis of dopamine (Thornburg and Moore, 
1973b). 
Neurochemicaliy, dopaminergic stimulation appears to 
reduce the release of ACh while cholinergic stimulation 
appears to increase the turnover of DA. Some of the experi-
ments which have demonstrated these effects are summarized 
here. Dopamine released via stimulation of the nigro-stri-
atal bundle blocks the release of ACh (Stadler~ al., 
1974). Similarly, apomorphine, amphetamine or L-DOPA in-
creases the level of ACh in the striatum (Sethy and Van 
Woert, 1974). The increase in ACh levels produced by apo-
morphine (Guyenet ~al., 1975) or ET-495 (Ladinsky ~ ..21..·, 
is blocked by neuroleptics but is not blocked by alpha-
methyl-p-tyrosine (Ladinsky ~al., 1974) or lesions of 
the nigro-striatal bundle (Guyenet ~al., 1975), sugges-
ting that the effect is mediated via dopaminergic receptor 
stimulation. Similarly, neuroleptic drugs increase the re-
lease of ACh with a resultant decrease in levels in the 
striatum (Stadler~ al., 1973; Guyenet ~ - al., 1975), and 
increase ACh turnover (Trabucchi ~al., 1974). Promethazine, 
a phenothiazine related to chlorpromazine which has little 
or no DA receptor blocking activity, does not alter ACh 
levels (Stadler~ al., 1973). This effect is noted in 
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the striatum, but not in other dopaminergic areas (Lloyd 
~al., 1973), nor is it noted in the hippocampus, which 
receives a rich cholinergic input but does not contain dopa-
mine terminals (Rommelspacher and Kuhar, 1975). These re-
sults are poorly correlated with the direct anticholinergic 
activity of the neuroleptics . (Rommelspacher and Kuhar, 1975) 
again suggesting that the effect is mediated by dopamine. 
These results have been interpreted to mean that striatal 
ACh is under an inhibitory influence of DA. However, lesions 
of the nigro-striatal pathway did not affect striatal ACh 
levels (Butcher and Butcher, 1974; Guyenet ~ ~., 1975). 
In an analagous manner, cholinergic drugs increase 
striatal dopamine turnover (Corrodi ~ al., 1967a) and 
the rate of formation of homovanillic acid (HVA) (Ahtee and 
Kaariainen, 1974). Similarly, anticholinergics reduce the 
turnover of striatal dopamine (Bowers and Roth, 1972; 
Corrodi ~ al., 1972a) and reduce the concentration of HVA 
(O'Keefe ~al., 1970). However, intraventricular infusion 
of atropine increases striatal HVA (Bartholini and Pletscher, 
1971). 
Of considerable interest is the additional interaction 
between ACh and DA in which anticholinergics have been re-
ported to inhibit the increase in DA turnover produced by 
the neuroleptics (O'Keefe ~al., 1970; Anden, 1972; Bowers 
and Roth, 1972). It appears that this effect is limited to 
the neuroleptic induced increase in striatal dopamine turn-
over, since the increase in turnover in limbic areas is un-
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affected by anticholinergics (Anden and Bedard, 1971; Anden, 
1972). 
2) Serotonin 
Behavioral evidence supporting an interaction between 
serotonin and DA has grown in recent years, although the 
evidence is not as strong as in the case of ACh (previous 
section). In general, increasing serotonergic activity 
opposes the effect of dopaminergic stimulation. 
Lycke and coworkers (1969) found that depressing the 
level of serotonin by parachlorophenylalanine (PCPA), an in-
hibitor of serotonin synthesis (Koe and Weissman, 1966), 
increased the excitation produced by DOPA and resulted in 
aggression in their mice. Similarly, PCPA enhances the 
stimulation produced by amphetamine (Mabry and Campbell, 
1973), while blocking serotonin receptors enhanced the stim-
ulation produced by apomorphine (Grabowska and Michaluk, 
1974). Breese and coworkers (1974) further investigated this 
relationship and observed thatpargyline reduced the stimulant 
effect of amphetamine and that this was correlated with an 
increase in serotonin levels. PCPA reversed the inhibition. 
Similarly, destruction of serotonin neurons with 5,6-dihy-
droxytryptamine likewise potentiated the amphetamine re-
sponse. PCPA was unable to alter the inhibition of amphet-
amine-induced stimulation produced by 6-hydroxydopamine 
(Breese~ al., 1974), suggesting that the serotonin effect 
is indirect. 
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Further evidence for an interaction between DA and 
serotonin has been provided by studies which measured ster-
eotypy produced after DA agonists, but these results have 
been contradictory. Decreasing serotonergic activity has 
been reported to increase the stereotypy produced by either 
amphetamine or apomorphine (Weiner et~·, 1973; 1975). 
However, it has also been reported that decreasing sero-
tonergic stimulation has no effect (Breese ~ al., 1974) 
and even decreases the stereotypy (Costall and Naylor, 
1975) induced by these DA agonists. 
It has also been reported that the catalepsy induced 
by neuroleptics is antagonized by PCPA or by . the destruc-
tion of raphe neurons (Kostowski ~al., 1972), lending 
further support to an interaction. 
The evidence thus suggests that activation of dopa-
minergic neurons leads to a compensatory increase in the 
activity of serotonergic neurons which results in a reduc-
tion of the effect of the initial dopamine stimulation 
(Grabowska and Michaluk, 1974; Cools, 1974). 
• 
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D. DOPAMINERGIC SUPERSENSITIVITY 
Supersensitivity refers to the phenomenon in which the 
amount of a substance required to ptoduce a given biological 
response is less than normal. This implies a shift in the 
dose response curve for an agonist to lower agonist concen-
trations. Such a shift in the dose response curve is con-
sidered the major criterion fo~ supersensitivity (Trendelen-
burg, 1966). Evidence for the concept of supersensitivity 
was provided by experiments in the peripheral nervous system. 
In early experiments, it was shown that spinal motor neur-
ons became more reactive to a variety of stimuli following 
transection of the spinal cord or destruction of sensory · 
nerve fibers (Cannon and Rosenblueth, 1949). Supersensiti-
vity in the periphery is considered to be of two types. 
In the first type, termed denervation supersensitivity, 
physical removal of the pre-junctions! nerve terminals leads 
to an enhanced effect of the neurotransmitter due to loss 
of the re-uptake function of the nerve terminal (Langer and 
Trendelenburg, 1966). In decentralization supersensitivity, 
the neurotransmitter fails to reach the target organ and 
leads to an actual increase in the sensitivity of the recep-
tor (Langer~ al., 1967). This type of supersensitivity 
was demonstrated by the enhanced response of the cat nicti-
tating membrane to norepinephrine following removal of the 
afferent nerves to the superior cervical ganglion (Langer 
~al., 1967). The time course of each type of supersensi-
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~~v~ty ±.a: d±.f:f~r~nt, with denervation supersensitivity re-
~u:.:fi.td.n:g: ~ s;iro:r.:ter period of time to develop. The actual 
tn:QJ~ecu:Lar ~e:e:.harrism by which supersensitivity occurs is 
wml£.nia:w;rr,, b:u..t:: s~veral suggestions have been made. There 
~~mll.cr fr~ ~ c:iiarrgE in the post-junctional element so that it 
actual.Ly ~e:c:o:nres more sensitive to the transmitter (Thesleff, 
i~&Q); the: me:chanism inactivating the transmitter could 
cr..hange s:n that: Lt is removed from its site of action more 
sl.awTy (Trencielenburg, 1963); or pre-ju~ctional elements 
caul.d increase their capacity to deliver transmitter or 
~hange theLr r~covery process to repetitive stim~lation 
«$harp.Les:a a:.rrci Jaffe, 1969). Many of these changes have 
been cienrcrn&t.r_a_t:ed in disused or denervated peripheral 
structures. 
Ln the ~entral nervous system, the term supersensitivity 
is l.aas:e:Ly a_p-p-1.i_ed to any procedure which results in an 
e.xag_ge rateci response to an agonis t. This has been studied, 
in dapa:nrine:rgLc brain areas, after eithe-r the destruction of 
neurons whLch supposedly synapse with dopamine receptors or 
after the ~dministration of drugs which decrease the avail-
abil.ity of doµamine for its receptors. In both cases, an 
enhanced r~s-p-orrse to stimulation by dopamine and related 
~ganists i~ p-resumed to occur as a compensatory adaptation 
to the l.~c:k of ~timulation as a result of the effect of 
trhe 1.es:i.an or t -h e drug • It should be noted that supersen-
sitivity has been used to explain the development of toler-
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ance to and physical dependence on drugs (e. g. Jaffe and 
Sharpless, 1968; Collier, 1966; Sharpless and Jaffe, 1969; 
Puri and Lal, 1973a), since withdrawal phenomena seem to 
represent rebound effects which are opposite in character 
to those produced by the drug itself. The characteristics 
of the two methods of producing supersensitivity in the 
CNS are described below. 
1) Lesion Induced Supersensitivity 
Intracerebral injections of 6-hydroxydopamine produce 
a degeneration of catecholamine containing nerve terminals 
in the CNS (Breese and Traylor, 1970; Uretsky and Iversen, 
1970). Following this treatment, rats exhibit a marked in-
crease in locomotor activity in response to L-DOPA (Uret-
sky and Schoenfeld, 1971) or apomorphine (Schoenfeld and 
Uretsky, 1972) as well as enhanced apomorphine-induced 
stereotypy (Iversen and Creese, 1975) and ET-495 induced 
hypothermia (Reid, 1975). Similarly, destruction of the 
substantia nigra results in enhancement of apomorphine-
induced stereotypy, while the stereotypy produced by am-
phetamine is blocked (Iversen and Creese, 1975). 
Unilateral destruction of dopaminergic nigro-striatal 
fibers or terminals provides an interesting model for the 
study of dopaminergic supersensitivity (Ungerstedt, 197la; 
Von Voightlander and Moore, 1973c). After such lesions, 
animals circle away from the side of the lesion in response 
to apomorphine and towards the side of the lesion in response 
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to amphetamine, presumably because apomorphine has more 
of an effect on the lesioned (supersensitive) side. An 
injection of 6-hydroxydopamine into the striatum, which 
induces this behavior, markedly decreases the concentration 
of dopamine but has little effect on norepinephrine or 
serotonin (Von Voightland~r and Moore, 1973c). In addi-
tion, the dose response curve for eliciting the turning 
by apomorphine or L-DOPA gradually shifts to the left over 
the course of 30 days (Thornburg and Moore, 1975). Similar-
ly, the rate of apomorphine-induced circling is well cor-
related with the reduction of forebrain dopamine (Thornburg 
and Moore, 1975). 
Following lesions of the substantia nigra, an enhance-
ment of striatal dopamine-stimulated adenylate cyclase has 
been reported (Mishra et .21.·, 1974) which would provide 
neurochemical substantiation for the supersensitivity. 
Furthermore, caffeine and theophylline enhanced the turn-
ing response to apomorphine in unilaterally lesioned rats, 
but failed to alter turning by themselves or that produced 
by amphetamine (Fuxe and Ungerstedt, 1974) which was inter-
preted as due to a preferential effect of these compounds 
on cyclic AMP formed in the lesioned (supersensitive) side. 
However, it has also been reported that there is no diff-
erence in caudate dopamine-stimulated adenylate cyclase 
after destruction of pre-synaptic nerve terminals by 
6-hydroxydopamine (Von Voightlander g al., 1973). Further 
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evidence for denervation supersensitivity is provided by 
Fibiger and Grewaal (1974) who found that in rats with uni-
lateral substantia nigra lesions, the effect of apomorphine 
in increasing striatal acetylcholine levels was greater on 
the lesioned side compared with the non-lesioned side, al-
though the response to hal0peridol was unaffected by the 
lesion. In addition, it is interesting to note that the 
dopamine cells which do not degenerate after 6-hydroxydop-
amine treatment have a higher rate of dopamine turnover than 
cells on the non-lesioned side (Agid ~al., 1973), which 
may represent another type of compensation for reduced dop-
amine stimulation on the lesioned side. 
2) Drug Induced Supersensitivity 
Changes in behavior during and after chronic adminis-
tration of drugs has long been recognized. Boyd (1960) 
noted a tolerance to the depressant effect of chlorproma-
zine after 30 weeks of treatment without a cross tolerance 
to pentobarbital. Furthermore, he noted an increase in lo-
comotor activity during "withdrawal" of the drug. Similarly, 
Moore (1968) reported a tolerance to the depressant effect 
of alpha-methyl-p-tyrosine (MPT) during chronic feeding of 
mice, despite the fact that catecholamine levels remained 
depressed. Similarly, daily treatment with reserpine led 
to enhanced locomotor activity when the drug was discon-
tinued which was correlated with an increase in norepine-
phrine stimulated adenyl cyclase (Williams and Pirch, 1974). 
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Subsequently, it was noted that exaggerated responses 
to dopamine agonist drugs could be elicited following chron-
ic treatment with drugs which would normally block their 
effect in naive rats. The stereotypy produced by amphetamine, 
apomorphine or methylphenidate was augmented following the 
cessation of repeated treatment with neuroleptics in rats 
(Schelkunov, 1967; Tarsy and Baldessarini, 1973), mice 
(Fjalland and Moller-Nielsen, 1974b) and guinea-pigs (Kla-
wans and Rubovits, 1972). This effect was also noted follo-
wing chronic MPT, but was not seen following chronic treat-
ment with the non-neuroleptics, pentobarbital or diazepam 
(Tarsy and Baldessarini, 1973), which do not affect CNS dop-
amine. Interestingly, it has been reported that this effect 
also fails to develop following chronic treatment with the 
novel neuroleptic, clozapine (Sayers~ al., 1975), a drug 
which does not block apomorphine stereotypy in naive rats 
(Stille~~., 1971). 
Similarly, amphetamine stimulation of locomotor acti-
vity was enhanced following chronic MPT, but the stimula-
tion produced by methylphenidate or pipradol, which is not 
blocked by MPT in naive animals, was unaffected following 
chronic MPT (Dominic and Moore, 1969). Concomitant admin-
istration of L-DOPA along with MPT, which would bypass the 
inhibition of catecholamine synthesis and prevents the de- · 
pletion of dopamine produced by the MPT, blocked the devel-
opment of supersensitivity (Gudelsky ~al., 1975). 
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Recently, it was shown that supersensitivity follo-
wing chronic haloperidol could also be demonstrated neuro-
physiologically (Yarbrough, 1975), such that a larger pro-
portion of caudate cells were inhibited by dopamine follo-
wing chronic haloperidol treatment. However, there is 
apparently no change in striatal dopamine-sensitive aden-
ylate cyclase activity in mice chronically treated with 
neuroleptics, although behavioral evidence of supersensiti-
vity was present (Von Voightlander ~al., 1975). 
Puri and Lal (1973a) proposed that a dopaminergic super-
sensitivity also develops during chronic treatment with 
narcotics. This suggestion was based on experiments in-
volving aggression during morphine withdrawal in which nor-
mally ineffective doses of apomorphine or amphetamine stim-
ulated the aggression (Lal et~., 1971; Puri and Lal, 
1973a). Subsequently, it was also shown that the reduction 
in striatal dopamine turnover produced by apomorphine 
could be elicited with ordinarily ineffective doses in 
morphine withdrawn rats (Puri and Lal, 1973b). 
III. EXPERIMENTAL 
A. Animals 
Male, hooded rats of the Long-Evans strain were ob-
tained from Charles River Breeding Farms, Wilmington, Mass-
achusetts and were use4 in this study. The rats weighed 
275-350 g at the start of experiments involving chronic drug 
treatment. Rats used for apomorphine-induced aggression 
weighed 375-475 g. The animals were housed : in a room with 
thermostatically controlled constant temperature (70°F or 
21°C ± 1°C) and an alternating period (12 hours) of light 
and dark (7 AM to 7 PM, light). They were allowed free 
access to food and water at all times unless otherwise 
stated. Rats used for chronic morphine treatment were 
housed in individual cages; all others were housed in stan-
dard colony cages. 
B. Drugs 
Drugs used in this study were: apomorphine hydrochlor-
ide (Mallinckrodt Chemical Works), morphine sulfate (Merck 
& Co.), haloperidol (Janssen Pharmaceutica and McNeil Labor-
atories), amphetamine sulfate (Smith, Kline & French), pilo~ 
carpine hydrochloride (Mallinckrodt Chemical Works), dexet-
imide (Rl6470) (Janssen Pharmaceutica), isopropamide (ZR79) 
(Janssen Pharmaceutica), naloxone hydrochloride (Endo La~-
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~~~t::ca::n:Le::s:), atropine sulfate (Mallinckrodt Chemical Works), 
~emtcrfra.:cl:i::U:.al sodium (Abbott Laboratories), cyproheptadine 
«M:e:r:c:k.,. s::ha:r:p-e & Dohme), clonidine hydrochloride (Boeringer-
1fni.&eih.e±m.) and alpha-methyl-p-tyrosine (MPT) methyl ester 
fuF<f:r::crc:h-Lo:ride (Aldrich Biochemicals). All drugs were fresh-
iy µ-re:p-ared and administered by the intraperitoneal route, 
EEC::e~t rn those experiments in which more than two drugs 
w-e:re: us:e:d:.. . rn these, the first drug was administered sub-
cu:t:a:rreau·ff'Ly. All drugs were dissolved in distilled water 
exc::e:pt halop-eridol and oxyperomide which were dissolved in 
~.3% tartaric acid and cyproheptadine which was solubilized 
w"f.trr th-e: aid of two drops of Tween 20. The doses and pre-
tre~tme:rrt times for the drugs are shown in Table 1. 
C. Chro·nic Drug Treatment 
i) M..crrp-h±.rre Addiction 
H~t& were made dependent on morphine by injecting them 
wf..th s:y~tematically increasing doses of morphine sulfate 
thre:~ times a day. The starting dose of 15 mg/kg/injection 
{45 mg/kg/day) was increased by 15 mg/kg/injection daily 
far rr±rre d:ays until a maintenance dose of 135 mg/kg/injection 
{405 m&/kg/day) was reached. The rats were maintained at 
th:f.5 dcr5e for at least five days. On the last morning, a 
ff.rra.1 rrriection of 135 mg/kg was administered, after which 
~a Eu.rthar morphine was injected. This was considered zero 
time of withdrawal. This is the usual addiction schedule 
TABLE 1 
DOSE RANGES Ai.~D PRE TREATMENT TIMES 
FOR DRUGS USED 
Dose Range Time Waited Before Testing 
Drug (mg/Kg) (minutes) 
a-amphetamine 0.1 - 16 60 
1-amphetamine 2 - 32 60 
apomorphine 0.5 - 20 10 
atropine 2.5 - 10 30 
clonidine 0.06- 0.50 30 
cyproheptadine 2 - 8 45 
dexetimide 0.32- 20 40 
haloperidol 0.16- 10 120 
isopropamide 2.5 - 5 30 
morphine 5 - 135 40 
MPT 100 - 300 240 
naloxone 1 - 16 10 
oxyperomide 1.25- 5 40 
pentabarbital 5 - 20 15 
pilocarpine 1.25- 10 15 
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utilized in this study. In early ·pilot experiments, other 
schedules were also employed. In these procedures, inject-
ions were given every 12 hours and the terminal dose was 
200 mg/kg/day. In the first schedule, a starting dose of 
10 mg/kg/injection was increased by 10 mg/kg/injection each 
day for 10 days. This is re~erred to as the short, low dose 
schedule. In the other, the starting dose of 5 mg/kg/injec-
tion was increased by 5 mg/kg/injection daily for 20 days. 
This is referred to as the long, low dose schedule. 
treatment schedules are illustrated in Table 2. 
2) Chronic Haloperidol 
These 
Rats wer~ injected with haloperidol twice daily be-
ginning with a dose of 2.5 mg/kg/injection. This dose was 
increased by 2.5 mg/kg/injection every fifth day until the 
terminal dose of 10 mg/kg/injection (20 mg/kg/day) was 
reached. This dose was maintained for four days. On the 
following morning, a final injection of 10 mg/kg was ad-
ministered after which no further haloperidol was injected 
and this was considered as zero time of withdrawal. 
schedule is also illustrated in Table 2. 
D. Brain Lesions 
This 
Under ether anaesthesia, bilateral elecrrolytic lesions 
were made with a monopolar, stainless steel electrode with 
a 0.5 mm non-insulated tip. A current of either 2 mA for 
3Q · seconds duration or 1 mA for 15 seconds duration gener-
TABLE 2 
SCHEDULES OF CHRONIC DRUG TREATMENTS 
Doseage of mg/Kg/injection (per day) 
Morphine Addiction Haloperidol 
Day Re9:ular Short, Low Long, Low 
1 15 (45) 10 (20) 5 (10) 2.5 ( 5) 
2 30 (90) 20 ( 4 0) 10 (20) 2.5 ( 5) 
3 45 (135) 30 (60) 15 (30) 2.5 ( 5) 
4 60 ( 180) 40 (80) 20 (40) 2.5 ( 5) 
5 75 (225) 50 (100) 25 (50) 5 (10) 
6 90 (270) 60 (120) 30 (60) 5 (10) 
7 105 ( 315) 70 ( 14 0) 35 (70) 5 (10) 
8 120 (360) 80 (160) 40 (80) 5 (10) 
9 135 ( 405) 90 (180) 45 (90) 7.5 (15) 
10 135 ( 405) 100 (200) 50 0.00) 7.5 (15) 
11 135 (405) 100 (200) 55 (110) 7.5 (15) 
12 135 ( 4 05) 100 (200) 60 (120) 7.5 (15) 
13 135 (405) 100 (lOO)a 65 (130) 10 (20) 
14 135 (13S)a 70 (140) 10 (20) 
15 75 (150) 10 (20) 
16 80 (160) 10 (20) 
17 85 (170) 10 (lO)a 
18 90 (180) 
19 95 (190) 
20-22 100 (200) 
23 100 (lOO)a 
Doses Per Day 3 2 2 2 
a Last injection of sequence (one morning injection). 
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ated by a Lesion Producing Device (Stoelting Co. Model 
58040) was passed through the electrode placed into the 
brain with a David Kopf Stereotaxic Instrument. With the 
dorsal cranium horizontal, the coordinates for the nigro-
striatal bundle were 1.5 mm posterior to bregma, 2.0 mm 
lateral to the midline suture and 8.5 mm below the surface 
of the cranium. Lesions of the medial forebrain bundle 
were placed 2.0 mm posterior to bregma, 1.5 mm lateral to 
the midline suture and 8.0 mm below the surface of the cran-
ium. 
E. Measurement of Withdrawal Signs 
At selected times after discontinuation of drug treat~ 
ment, rats were removed from their home cages and placed in-
dividually into a novel cage. Signs were measured for 30 
minutes. The signs which were noted consisted of "wet shakes," 
defined as the violent shaking movement of the head or body 
which resembles movements made by an animal which has been 
drenched with water; writhing, defined as the dragging of 
the abdomen along the floor of the cage and drawing in of 
the abdominal wall (Buckett, 1964) unaccompanied by yawn-
ing; ptosis, defined as the drooping of the eyelids to form 
a slit-like appearance, unaccompanied by sleep; piloerection; 
diarrhea and teeth chattering. The frequency of "wet 
shakes" and writhing was noted during the observation ses-
sion along with the duration of ptosis. The presence or 
absence of the other sjgns was noted as present or not present. 
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In addition, the rat was weighed and his colonic 
temperature was measured onehour after receiving the final 
injection of morphine. The temperature was measured using 
a digital thermistor thermometer (Digitec Model 581C, Un-
ited Systems Corp.). The rectal probe was inserted 5 cm 
and maintained in place for one minute before recording 
the temperature. Immediately prior to the observation 
session, the rats were again weighed and their temperatures 
taken. These values were compared with the initial meas-
urement in order to establish the magnitude of change in 
weight and temperature. The descriptions and measurements 
of these signs may be found in Gianutsos ~ .2:.1.· (1975). 
F. Aggression 
Aggression was measured by placing similarly treated 
rats in groups of four into a chamber (23 cm X 20 cm X 19 
cm) made of Plexiglas with a wire floor. The walls of the 
chamber were covered with a sound-absorbing rubber material, 
with the front left uncovered to allow for observations. 
The rats were observed for one hour during which time, 
three parameters of aggression were measured as described 
in Lal (1975). These were: attacks (including bites), rear-
ing time and vocalizations. An attack was recorded each 
time one rat bit, violently shoved or leaped upon another 
animal. Rearing time consisted of the total elapsed time, 
in seconds, in which two or more rats assumed an aggressive 
posture in which they stood on their hind paws facing each 
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other in close proximity with their mouths open and vocal-
izing or when one rat stood over another while vocalizing. 
These typical postures are illustrated in Figures lA and 
lB. Vocalizations were monitored via an audio detection 
relay (Scientific Prototype Model 761-G) which automatically 
sent a pulse to a counter when a vocalization was made. 
The relay was modified to detect sounds in the range of 
2400-4800 Hz. All three parameters were recorded for 
six consecutive 10 minute intervals and were summed to 
arrive at the figures for responses per hour. Each group 
of rats was treated statistically as one subject. 
G. Locomotor Activity 
At various time intervals after drug treatment (see 
Table 1), rats were placed individually in clear Plexiglas 
bins (42 cm X 27 cm X 16 cm) on top 0 f a Selective Activity 
Meter (Columbus Industries, Model S) for the measurement of 
locomotor activity. Each meter was enclosed within a sep-
arate wooden cabinet equipped with a fan and a house light, 
both of which were constantly on during the activity meas-
urements. 
Each time the rat crossed one of the six electromag-
netic sensors on the meter, a count was recorded. The 
counts were accumulated in a print-counter (Data Pac, 
LVE/BRS Model No. 421-09) and printed out at 10 minute in-
tervals, The counts for one hour (six consecutive 10 minute 
intervals) were summed and activity was expressed as counts 
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per hour. All activity measurements were made during the 
morning. 
H. Stereotypy 
Stereotypy was measured by placing rats into individual 
cages (24 cm X 18 cm X 17.5 cm) with a wire grid floor and 
front. The rats were observed during five consecutive five 
minute observation periods. Each observation period was 
separated from the next observation by a five minute re-
cess. The rats were observed at O, 10, 20, 30 and 40 min-
utes after the session began. 
During the observation period, the rats were rated for 
the intensity of stereotypy according to the five point 
scale devised by Ernst (1967). The ratings were as follows: 
0 - No stereotyped movements. 
1 - Rats walking around cage, sniffing over grid, 
occasionally licking the wires and putting 
t ·heir nose in the grids. 
2 - Rats moving around, occasionally biting and 
gnawing at the wires. 
3 - Rats restricting their locomotion to a small 
area and gnawing intensely at the bottom. 
4 - Rats remaining on the same spot for at least 
5 minutes while jerkingly gnawing and clinging 
their teeth around the wires convulsively for 
longer periods, sometimes interrupted by short 
intermissions. 
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I. Dopamine Turnover 
The rate of dopamine turnover was evaluated by measuring 
the rate of disappearance of dopamine from the corpus stria-
tum after the administration of alpha-methyl-p-tyrosine (MPT) 
methyl ester hydrochloride (300 mg/Kg), which inhibits the 
synthesis of the catecholamines (Spector~ 2-1·, 1965). The 
animals were deprived of food for 18-24 hours prior to being 
sacrificed by decapitation. The brains were rapidly removed 
from the cranium and placed on ice. The lateral ventricles 
were opened to expose the corpus striatum which was removed 
from each side and pooled. All manipulations were carried 
out on ice using ice-chilled equipment. The striata were 
weighed and homogenized in 3 ml of 0.4 N perchloric acid 
containing 0.05% sodium metabisulfite. The homogenate was 
transferred to a centrifuge tube. The homogenizer was 
rinsed with 1 ml perchloric acid solution which was added 
to the homogenate and centrifuged at 12,000 X g for 10 min-
utes in a Servall RC 2B refrigerated centrifuge. 
The supernatant from each centrifuge tube was trans-
ferred into a large centrifuge tube containing 10 ml of 
0.5 M tris buffer (pH 9.5). The resultant pH of the sample 
was 8.5 + 0.1. The samples were allowed to pass through a 
9 mm glass column packed with 500 mg of alumina at a rate 
of 30 drops a minute. The eluate as well as a 5 ml dis-
tilled water wash were discarded. The dopamine on the col-
umn was then extracted by 4 ml of 0.2 N acetic acid and col-
lected in a graduated centrifuge tube containing 1 ml of 
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EDTA reagent. A two and a half ml sample was transferred 
to a test tube and assayed spectrofluorometrically (Carlsson 
and Waldeck, 1958). To the test tube was added 0.2 ml of 
iodine solution and shaken. Exactly three minutes later, 
0.2 ml alkaline sulfite was added. Tissue blanks were pre-
pared from the residual acetic acid eluate with the addition 
of alkaline sulfite and iodine reversed. Exactly three 
minutes after the addition of alkaline sulfite, 0.5 ml of 
5N acetic acid was added to each test tube and placed into 
a bath of boiling water for five minutes. Once they had 
cooled to room temperature, the concentration of dopamine 
in each sample was estimated by reading the samples at 370 
nm while activating at 320 nm in an Aminco-Bowman Spectra-
fluorometer. The concentration of dopamine in the exper-
imental samples was determined by comparing the fluorescence 
with the known concentraiion of a standard dopamine solution. 
The calculated concentration was expressed as micrograms of 
dopamine per gram of wet tissue. Recovery was found to be 
88%. The samples were not corrected for the recovery loss. 
The turnover of dopamine was calculated from the rate 
of striatal dopamine depletion observed two hours after the 
injection of MPT according to the method of Costa and Neff 
(1970). The quantity of dopamine in the sample obtained 
after the MPT was compared with the quantity in the striatu~ 
immediately after the HPT injection. The calculation of 
dopamine turnover was carried out using the URI IBM Systems 
370 computer and consisted of solving the equation: 
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Log DAt = Log DA 0 - 0.434 kt 
where DA is the initial steady state concentration of dop-
o 
amine, DAt is the concentration of dopamine at any time, t, 
after the administration of MPT and k is the fractional rate 
constant. Multiplication of k by the initial steady state 
level of dopamine yields the. apparent turnover rate. 
J. Statistics 
The following statistical procedures were used in this 
study: When differences were obvious, no statistical pro-
cedure was used. Student's "t" test was employed for com-
parisons involving two groups. Multiple comparisons were 
made using the Tukey (b) test except in those cases where 
all comparisons were made with control, in which case Dun-
net's test was used. In one experiment, where the compar-
ison was planned a priori, the Test of Individual Compar-
isons was utilized. All procedures are described in Winer 
(1971). 
Where data followed a binomial distribution, the Chi 
Square Test was used. In those instances in which the data 
was on an ordinal scale, or seriously violated certain as-
sumptions of parametric statistics, the Mann Whitney Test 
or the Kruskal-Wallis Analysis of Variance was used, depen-
ding on the number of groups being tested. These proced-
ures are described in Conover (1971). Multiple comparisons 
were made in these cases by Dunn's Procedure (Hollander and 
Wolfe, 1973). 
I~. RESULTS 
The results of this investigation are divided into 
three sections: aggression induced by apomorphine in naive 
rats; morphine withdrawal aggression; and behaviors follo-
wing chronic haloperidol. 
A. Apomorphine Induced Aggression in Naive Rats 
Apomorphine produced aggression in a dose-dependent 
manner as illustrated in Figure 2. This was determined for 
use in subsequent experiments. The aggression was charac-
terized by vocalizations, aggressive postures and attacks 
and biting. At the higher doses, this frequently led to se-
vere injury and bleeding. Doses less than 2.5 mg/kg failed 
to produce any aggression, while the 5 mg/kg dose produced 
aggression in approximately 20 per cent of the groups tested. 
The 20 mg/kg dose reliably produced a substantial aggression 
and was utilized in further studies. Doses of 5 mg/kg or 
less were used in studies where it was predicted that the 
treatment would increase the aggression. 
1) Effect of Anti-Dopaminergic Drugs 
If the aggression is due to dopaminergic hyperactivity, 
it would expected that drugs which reduce dopaminergic ac-
tivity would also reduce the aggression. Drugs from two 
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Fig. 2--Dose related elicitation of aggres-
sion by apomorphine in naive rats. Apomorphine was 
injected into groups of four rats, five minutes pri-
or to observations. Points are mean + S. E. for 
five different groups. Attacks were counted by the 
experimenter. Rearing refers to the time, in seconds, 
spent in .aggressive postures (see Figures la, lb). 
Vocalizations were counted automatically. The rats 
were observed for one hour. The dose of the drug 
was well correlated with the intensity of aggression 
on all three measures ( attacks: r= 0.78; rearing: 
r= 0.82; vocalizations: r= 0.80). 
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different classes which decrease dopamine activity were used, 
neuroleptics and narcotics (see Section TI.B). 
The neuroleptics, haloperidol and oxyperomide, produced 
a dose-dependent reduction of the aggression induced by the 
20 mg/kg dose of apomorphi~e (Table 3). This effect was no-
ted on all three parameters of aggression measured. Haloper-
idol was maximally ~ffective at a dose of 2.5 mg/kg, while 
the 5 mg/kg dose of oxyperomide abolished the aggression. 
Similarly, morphine produced a dose-dependent blockade of 
the apomorphine-induced aggression, with a dose of 10 mg/kg 
being maximally effective (Table 4). The morphine-induced 
blockade of aggression was prevented by the narcotic antag-
onist, naloxone, which had no effect of its own. The spec-
ificity of this effect is evident from the fact that nal-
oxone had no effect on the reduction in aggression produced 
by haloperidol (Table 4). These results confirmed the sus-
pected anti-aggression action of anti-dopaminergic drugs. 
In contrast to the effect of naloxone, an anticholin-
ergic drug, dexetimide, partially reversed the anti-aggres-
sion action of haloperidol or oxyperomide as illustrated in 
Table 5. This effect was produced by doses of dexetimide 
which apparently had little effect on apomorphine-induced 
aggression of their own (c.f. Table 9). However, dexetimide 
was unable to alter the blockade of aggression produced by 
morphine (Table 5), suggesting that morphine and the neuro-
leptics produce their effects by different mechanisms. Tf 
..._ __________ _ 
TABLE 3 
EFFECTS OF NEUROLEPTICS ON 
APOMORPHINE-INDUCED AGGRESSION 
Aggressive Response/Hour 
(mean ± S. E. ) 
Dose 
Drug (Mg/Kg) N3 Attacks Rearing Vocalizations 
Saline 5 61 ± 9 2750 ± 251 2219 ± 
Haloperidol 0.63 2 59 ± 5 2358 ± 756 1351 ± 
1.25 5 28 ± 8 2358 ± 544 1190 ± 
2.5 5 2 ± 2 89 ± 89 17 ± 
Oxyperomide 1. 25 2 52 + 2 2621 + 220 889 + 
2.5 5 15 + 6 1163 + 510 386 + 
- - -
5.0 5 2 + 2 33 + 33 25 + 
- - -
1 Apomorphine (20 mg/Kg) was injected into all _ groups 
2 Haloperidol was injected two hours before testing while 
oxyperomide was injected 40 minutes before testing. 
3 Number of groups (four rats per group) tested. 
204 
97 
487 
15 
95 
148 
25 
Values for haloperidol (2.5 mg/Kg) and oxyperomide (5 mg/Kg) 
are significantly different (P(0.05) from saline control (Dunn's 
Procedure) . 
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TABLE 4 
EFFECT OF MORPHINE ON APOMORPHINE-INDUCED AGGRESSIONl 
Dose 
Drugs2 (mg/Kg) N3 Attacks 
Saline 5 58 + 10 
-
Morphine 5 5 28 + 11 
-
10 5 1 + 1 
Naloxone 4 
+ 5 42 + 5 
-Morphine 10 
Haloperidol 2.5 
+ 3 0 
Naloxone 4 
Naloxone 4 3 46 + 5 
Aggressive Response/Hour 
(mean ± S. E.) 
Rearing 
(secs) Vocalizations 
1787 + 301 1188 + 252 
- -
1150 + 285 702 + 221 
- -
30 + 30 10 + 10 
1654 + 384 1163 + 196 
- -
0 0 
2189 + 263 1283 + 107 
1Apomorphine (20 mg/Kg) was injected into all groups 
2Morphine was injected 40 minutes before testing, haloperidol 
was injected 2 hours before testing and naloxone was injected 
10 minutes before testing. 
3Number of groups (4 rats/group) tested. 
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TABLE 5 
REVERSAL OF NEUROLOPTIC-INDUCED BLOCKADE OF APOMORPHINE-INDUCED AGGRESSIONl 
BY DEXETIMIDE 
Aggressive Responses/Hour 
(mean ± S. E. ) 
Pre-Treatment Post-Treatment 
Drug Dose Drug Dose N Attacks Rearing Vocalizations 
Saline - Saline - 5 47 + 10 1633 + 315 1119 ± 306 
Haloperidol 2.5 Saline - 3 3 + 3 71 + 71 22 + 23 
- -
°' V1 
Dexetimide 1. 25 2 18 ± 4 986 ± 152 583 ± 120 
2.5 6 14 + 3 571 ± 191 403 ± 109 
5.0 3 45 + 4 1392 + 209 1214 + 342 
- -
Oxyperomide 5 Saline - 3 0 0 0 
Dexetimide 1. 25 4 19 ± 9 615 + 278 433 ± 207 
2.5 4 20 ± 4 562 ± 118 388 ± 110 
5.0 3 37 ± 13 1087 ± 389 998 ± 303 
Morphine 10 Saline - 3 0 0 0 
Dexetimide 1. 25 3 1 ± 0 6 ± 5 12 ± 9 
2. 5 . 3 0 0 0 
5.0 6 4 -+ 2 76 + 52 101 ± 51 
lAll groups were injected with apomorphine (20 mg/Kg) following treatment with other 
drugs 
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an anticholinergic drug reverses the neuroleptic effect, a 
cholinergic drug should synergiz~ with the neuroleptic. As 
can be seen in Table 6, the combination of an approximately 
ED50 dose of oxyperomide w~th an ED 50 dose of the cholinergic 
drug, pilocarpine, resulted in a reduction of aggression 
which was greater than either drug alone. These results 
suggest a reciprocal interaction between dopamine and acetyl-
choline. If so, cholinergic stimulation should decrease 
apomorphine-induced aggression. 
2) Effect of Drugs Affecting Acetylcholine 
Data summarized in Table 7 shows that pilocarpine re-
duced the aggression induced by the 20 mg/kg dose of apo-
morphine in a dose-dependent manner, with the dose of 5 
mg/kg of pilocarpine being maximally effective. The ex-
periments summarized in Table 8 were designed to test the 
effect of various anticholinergics on the pilocarpine-in-
duced blockade of aggression. The data is divided into 
two consecutive 30 minute segments, rather than a one hour 
observation period as usually presented. This is because 
it was noted that the centrally active anticholinergics, 
dexetimide and atropine, when combined with the high dose 
of apomorphine used in this experiment, resulted in con-
vulsive-like toxic effects towards the middle of the ob-
servation period. These convulsions became apparent after 
the rats had begun to fight. Therefore, the measurements 
recorded in the first period . were analyzed separately from 
TABLE 6 
EFFECT OF PILOCARPINE PLUS OXYPEROMIDE ON APOMORPHINE- l 
Drug N2 
Sali _ 6 
Pilocarpine3 6 
Oxyperomide4 6 
Pilocarpine3 
+ 6 
Oxyperomide4 
INDUCED AGGRESSION 
Attacks 
53 + 4 
30 + 6 
28 + 6 
4 ± 3* 
Aggressive Responses/Hour 
(mean ± S. E.) 
Rearing 
(secs) Vocalizations 
2702 + 122 1693 + 221 
1621 + 334 451 + 88 
1410 + 434 745 + 245 
465 ± 307* 125 ± 94 
* Significantly different (p<0.05) from pilocarpine or oxy-
peromide alone by Test of Individual Comparisons (Winer, 
1971.) 
1 20 mg/Kg of apomorphine injected into all groups. 
2 Number of (4 rats per group) tested. groups 
3 2.5 mg/Kg 10 minutes before testing. 
4 2.5 mg/Kg 40 minutes before testing. 
TABLE 7 
BLOCKADE OF APOMORPHINE1 -INDUCED AGGRESSION BY PILOCARPINE 
Aggressive Responses/Hour (Mean+ S.E.) 
Dose of 
Pilocarpine2 Rearing 
(m9/Kg) N Attacks/Bites (seconds) Vocalizations 
0 7 51 + 9 1929 + 261 1222 + 204 
2.5 5 33 + 12 1363 + 572 291 + 114 
5 5 1 ± l* 81 ± 81* 16 ± 14* 
10 3 0 + 0 0 + 0 0 + 0 
* Significantly different (P '- 0. 05) from control (Dunn's Proce-
dure) 
1Apomorphine (20 mg/Kg) was injected into all :!'.·ats. 
2Pilocarpine (or saline) was injected 15 minutes before test-
ing. 
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Dru9: 
None 4 
Salines 
·a 6 IsopropamJ . . e 
Dexetimide 
Atropine 
TABLE 8 
EFFECT OF ANTICHOLINERGICS ON PILOCARPINE-INDUCED BLOCKADE OF 
APOMORPHINE-INDUCED AGGRESSION! 
Responses/30 Min (Mean+ S.E.) 3 
First 30 Minutes Second 30 Minutes 
Dose Rearing Rearing 
(mg/Kg) N2 Attacks (secs) Vocalizations Attacks (secs) 
- 5 19 ± 8 729 ± 271 493 ± 219 32 ± 9 1200 ± 268 
- 5 0 0 0 0 0 
2.5 5 0 0 0 0 0 
0.63 3 0 0 55 ± 35 0 1 + 1 
-
1. 25 3 3 + 2 170 + 158 103 + 54 9 + 3 183 ± 99 
2.5 8 9 + 4 440 + 157 223 ± 68 4 i 2 209 ± 126 
5 5 16 + 6 458 + 135 331 + 107 4 + 2 71 + 35 
- -
5 3 5 + 5 171 + 171 139 + 113 5 + 5 338 + 338 
- -
10 3 8 + 4 164 + 101 132 + 72 8 + 4 231 + 153 
1 
Apomorphine 20 mg/Kg was injected into all groups . 
2 Number of groups tested (4 rats/group) 
Vocalizations 
729 ± 201 
0 
0 0\ 
"° 
3 + 3 
-
159 + 101 
134 ± 54 
105 + 38 
-
201 + 201 
265 + 157 
Table 8 Continued 
3 
Groups were observed for two consecutive 30 minute periods (see text). 
4 Apomorphine alone 
5 This group and all subsequent groups received apomorphine + pilocarpine (5 mg/Kg) and the 
appropriate drug. 
6 This does of isopropamide blocked pilocarpine-induced (5 mg/Kg) diarrhea. 
" 0 
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the second segment in order to take the convulsions into 
account for proper interpretation of the data. Dexetimide 
and atropine partailly reversed the blockade of .aggression 
by pilocarpine in the first period. During the second half 
of the observation, these drugs were ineffective in rein-
stating the aggression, but this effect is probably an arti-
fact attributable to the hyperstimulation and convulsions 
produced by the drug combinati~ns. The third anticholinergic 
drug used, isopropamide, does not penetrate into the CNS 
(Janssen and Niemegeers, 1967). Isopropamide effectively 
blocked the dlarrhea produced by the pilocarpine at the 
dose used (2.5 mg/kg) but had no effect on the aggression-
blocking property of pilocarpine, indicating that the effect 
of cholinergic stimulation in inhibiting aggression is 
centrally mediated. 
Since the cholinergic drug, pilocarpine, blocked the 
aggression produced by apomorphine,it would be expected 
that an anticholinerg i c ma y increase the aggression. Large 
doses of dexetimide were combined with a threshold dose 
(5 mg/kg) and a sub-threshold dose (2.5 mg/kg) of apomorphine 
(see Figure 2). Dexetimide alone, in any dose including one 
as high as 20 mg/kg, was unable to elicit aggression in the 
rats (Table 9), although signs resembling amphetamine agit-
ation were present at this dose. However, dexetimide in a 
dose of 10 mg/kg elicited aggression when combined with a 
sub-threshold dose of apomorphine and signif i cantly incr-
eased the aggression produced by threshold doses of apomor-
TABLE 9 
EFFECT OF DEXETIMIDE ON APOMORPHINE INDUCED AGGRESSION 
Dose (mg/Kg) 
Aggressive Responses/Hour 
(Mean ± S.E.) 
Attacks/ Rearing 
Apomorphine Dexetimide1 N2 :e.j tes (secs) Vocalizations 
0 20 3 0 0 0 
2.5 0 5 0 0 3 + 1 
5 5 0 0 110 + 72 
10 5 11 + 6* 244 ± 148* 427 + 171* 
5.0 0 5 4 + 4 257 + 257 148 + 148 
2.5 3 5 + 5 261 + 261 177 + 177 
5 6 21 + 6* 876 + 147* 651 ± 183* 
* Significantly different from corresponding no dexetimide group 
(p <.OS) by student's test. 
1Dexetimide was injected 30 minutes before apomorphine. Tests 
were made 5 minutes later. 
~Number of groups (4 rats/group) tested. 
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phine at a dose of 5 mg/kg (Table 9). 
3) Effect of Amphetamine~ 
rt was predicted that amphetamine, which releases dop-
amine, would intensify the apomorphine-induced aggression. 
Amphetamine, at a dose of 8 mg/kg, did exacerbate the aggres-
sion produced by threshold doses of apomorphine ·cs mg/kg), 
but failed to elicit aggression when combined with sub-thres-
hold doses of apomorphine (Table 10). Doses higher than 
those reported produced severe toxic reactions when the rats 
were placed in the small confinement used for testing. Since 
amphetamine releases norepinephrine and serotonin (McLean 
and McCirtney, 1961) as well as dopamine, an investigation 
into the possible role of these other transmitters as an-
tagonists of an amphetamine effect on aggression was under-
taken. 
Clonidine, which stimulates alpha noradrenergic recept-
ors (Anden ~ ~., 1970b) was used to explore the role of 
norepinephrine. As is illustrated in Table 11, combinations 
of clonidine and sub-threshold doses of apomorphine resulted 
in a marked and dose-dependent increase in the aggression. 
Doses of clonidine as small as 0.13 mg/kg produced a violent 
behavior characterized by an excessively large proportion of 
biting when combined with normally ineffective doses of apo-
morphine. 
The serotonergic influence was measured in two ways. 
Some preliminary data is presented in Table 12 in wh~ch 
TABLE 10 
EFFECT OF AMPHETAMINE ON APOMORPHINE-INDUCED AGGRESSION 
Amphetamine2 
Aggressive Responses/Hour 
(mean ± S. E.) 
- ---Rearing Apomorphine
1 
Dose Dose N3 Attacks Secs) Vocalizations 
-
2.5 0 4 0 0 0 
8 4 0 0 31 ± 31 
12 2 0 0 27 ± 27 
5 0 5 4 + 4 101 + 101 81 + 66 
8 5 26 + 9* 1058 + 359* 747 ± 242* 
* Significantly different (p<0.05) from no amphetamine group. 
(Student's t test) 
1 Injected five minutes before grouping. 
2Injected 60 minutes before testing. 
3 Number of groups (four rats per group) tested. 
....... 
.i:--
TABLE 11. 
EFFECT OF CLONIDINE ON APOMORPHINE-INDUCED AGGRESSION 
Drug 
Saline2 
Clonidine2 
(+ apomorphine) 
Clonidine3 
(alone) 
Dose 
(mg/Kg) 
0.07 
0.13 
0.25 
0.25 
0.50 
Nl 
4 
4 
4 
4 
3 
2 
Aggressive Responses/Hour 
(mean ± S .E.) 
Attack Rearing Vocalizations 
0 0 0 
3 + 3 73 + 73 16 + 16 
27 ± 9 1163 + 409 404 + 162 
- -
51 + 3 1364 + 209 605 + 78 
0 0 0 
0 0 0 
1 
Number of groups (four rats/group) tested. 
2 The drug was administered 25 minutes prior to apomorphine 
(2.5 mg/Kg). Observations were made five minutes later. 
3
clonidine was injected 30 minutes before observation. No 
other drug was administered. 
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TABLE 12 
EFFECT OF AMPHETAMINE PLUS CYPROHEPTADINE ON APOMORPHINE 
INDUCED AGGRESSION 
Aggressive Responses/Hour 
(mean ± S . E. ) 
Apomorphine 
Dose 
Drugl (mg/Kg) 
Saline 1. 2S 
Amphetamine 3 1. 2S 
Amphetamine~ 
+ 1. 2S 
Cyproheptadine4 
Saline 2.S 
Amphetamines 2.S 
Cyproheptadine6 2.S 
Amphetamines 
+ 6 2.S 
Cyproheptadine 
N2 
3 
3 
3 
4 
4 
2 
4 
Attacks 
0 
0 
6 + 6 
0 
·o 
0 
20 + 11* 
Rearing 
(secs) 
0 
0 
186 + 186 
0 
0 
0 
966 + S83* 
* Significantly different (p~O.OS) from saline ~ontrol (Mann Whitney Test) 
1 Drugs were injected followed by apomorphine at the indicated doses. 
Vocalizations 
0 
18 + 18 
103 + 87 
0 
30 ± 30 
0 
49S + 167* 
-...J 
°' 
TABLE 12 continued 
2 
Number of groups tested (4 rats per group). 
3 8 mg/Kg. 60 minutes before testing. 
4 8 mg/Kg. 45 minutes before testing. 
5 
4 mg/Kg. 60 minutes before testing. 
6 4 mg/Kg. ·45 minutes before testing. 
-...J 
-...J 
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cyproheptadine, a blocker of serot-0nin receptors (Stone et 
·a1., 1961), was used. When c o·m b in e d with ·amp he tam in e , c y-
proheptadine appeared to produce a weak elicitation of ag-
gression by sub-threshold do$es of apomorphine. Cyprohept-
adine alone, at the doses used, d i d not influence the apo-
morphine-induced aggression. . Secondly, parachloroampheta-
mine (PCA), a related phene~hylamine which produces a long-
lasting depletion of brain serotonin (Sanders-Bush .!U_ ~·, 
1972) markedly lowered the effective dose of apomorphine. 
When PCA was given in a dose of 12 mg/kg, three days be-
fore testing, there was no spontaneous aggression in the 
rats, but there was considerable aggression a~ter small 
(0.63- 2.5 mg/kg), normally ineffective doses of apomor-
phine (Figure 3). These results would suggest that sero-
tonin opposes dopamine-induced aggression. 
I 
B. Morphine Withdrawal Aggression 
1) 72 Hour Withdrawal Aggression 
Morphine withdrawal aggression was studied because it 
also may have a dopaminergic basis (Puri and Lal, 1973a). 
Any similarities between morphine withdrawal aggression 
and apomorphine-induced aggression would provide further 
support for the mechanisms proposed. 
a} Effect of Dopamine 
Rats were made dependent on morphine by the three 
methods described in Section III.c.l. As expected, the 
Fig. 3--Dose related elicitation of aggres-
sion by apomorphine in p-chloroamphetamine (PCA) 
treated rats. Apomorphine was injected into groups 
of four rats, three days after PCA (12 mg/kg in a 
single injection). Points are mean+ S. E. for four 
groups, except for the 2.5 mg/kg dose of apomorphine 
which represents data for one group. Apomorphine or 
saline was injected five minutes before observations. 
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rats addicted to a terminal dose of 405 mg/kg/day demonstr-
ated considerable aggression 72 hours after their last mor-
phine injection (Table 13). Decreasing the amount of morph-
ine injected during addtction to a terminal dose of 200 mg/kg 
resulted in significantly less aggression during withdrawal 
on all three parameters tested, while increasing the length 
of time that the rats received morphine injections from 15 
to 25 days, while maintaining the terminal dose at 200 mg/kg, 
produced aggression which was indistinguishable from the us-
ual high dose schedule (Table 13). This indicates that the 
degree of aggression is dependent on the amount of morphine 
administered and the duration of addiction. The high dose 
schedule was utilized for all further experiments. 
It is interesting to note that the aggression peaks at 
72 hours of withdrawal, while other signs of withdrawal 
(e. g. "wet shakes", ptosis, hypothermia), peak at 24-48 
hours of withdrawal (Martin il al., 1963; Gianutsos il tl·, 
1975). Spontaneous locomotor activity was also measured 
during withdrawal to determine if any pattern was evident. 
It can be seen from the data summarized in Table 14 that 
locomotor activity was significantly lower than in normal 
rats at 48 hours of withdrawal, when most signs - of withdra-
wal are at their most intense. The activity was signifi-
cantly higher than control at 72 hours of withdrawal, when 
aggression was at its maximum. 
24 hours of withdrawal. 
The activity was normal at 
TABLE 13 
EFFECT OF DIFFERENT SCHEDULES OF ADDICTION ON 72 HOUR 
MORPHINE WI THDRAWAL AGGRESSION 
Aggressive Responses/Hour 
(mean :t S. E. ) 
Terminal Length of2 
Dos el Addiction 
N3 
Rearing 
(mg/Kg) (days) Attacks (secs) Vocalizations 
* 
1 
2 
405 14 13 32 ± 2 3216 ± 118 1864 ± 150 
200 15 6 13 + 4* 1877 + 532* 904 + 323 
- - -
200 25 3 29 + 5 3399 + 161 2524 + 103 
Significantly different (p~0.05) from 405 group (Student's 
t test) . 
Final daily dose of morphine at which rats were maintained 
(see methods) . 
Total number of days during which morphine injections were 
given. 
3 Number of groups (4 rats per group). 
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TABLE 14 
LOCOMOTOR ACTIVITY OF RATS DURING MORPHINE WHTHDRAWAL 
Period of Locomotor Activity Counts 
Withdrawall N (mean ± S. E.) 
Control2 10 1138 + 106 
24 hours 10 1101 ± 131 
48 hours 10 810 + 94* 
72 hours 10 1429 ± 101* 
* Significantly different (p<:.0.05) from control (Dunnet's 
Test) 
1 Hours since last morphine injection (135 mg/Kg) 
2 Naive, non-addicted rats 
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As expected from the data of .Puri and Lal (1973a), 
a small dose of apomorphine (1.25 mg/kg} increased, while 
haloperidol (0.64 mg/kg) decreased the 72 hour morphine 
withdrawal aggression (Table 15). Lesions of the dopamin-
ergic nigro-striatal bundle (NSB) re duced the intensity of 
the aggression (Table 16). Small lesions (1 mA, 15 sec) of 
the bundle decreased aggression by about 50 per cent, while 
more extensive lesions (2 mA, 30 sec) produced a virtually 
complete blockade ot the a~gression. These lesions have 
been shown to produce the characteristic rise in dopamine 
levels in the striatum 24 hours after the lesion, followed 
by a gradual depletion of striatal dopamine, ~ith the lar-
ger lesion producing a more complete depletion (Hynes .!:l. 
al.", 1975). These results provide further evidence for the 
dopaminergic basis of morphine withdrawal aggression. 
In contrast to the effects in normal rats (c.f. Table 
5), dexetimide did not affect the blockade of aggression by 
·haloperidol in morphine withdrawn rats (Table 17). It was 
determined in pilot experiments that the 0.64 mg/kg dose of 
haloperidol which was used in this study was the minimum 
effective dose in blocking withdrawal aggression. Dexetimide 
by itself did not reduce the aggression, while the combina-
tion of haloperidol and dexetimide produced the usual blocKade 
of aggression (Table 17). These results suggest an altera-
tion of the normal dopaminergic/cholinergic balance during 
morphine w·ithdraw-al and point up the first difference be-
tween morphine withdrawal aggression and apomorphine-induced 
TABLE 15 
EFFECT OF APOMORPHINE OR HALOPERIDOL ON 72 HOUR 
MORPHINE WITHDRAWAL AGGRESSION 
Aggressive Responses/Hour 
(mean ± S. E.) 
Dose Rearing 
Drug (mg/Kg) Nl At.tacks (secs) Vocalizations 
Saline 5 30 + 3 3060 + 315 1771 + 181 
- - -
Apomorphine 2 1. 25 7 82 + 5 3324 + 210 1995 ± 377 
Haloperidol 3 0.64 4 0 ± 0 3 ± 3 15 ± 11 
1 
Number of groups (4 rats/group) tested. 
2 Apomorphine or saline was injected 5 minutes before testing. 
3 Haloperidol was injected 2 hours before testing. 
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TABLE 16 
EFFECT OF BRAIN LESIONS ON 72 HOUR MORPHINE WITHDRAWAL 
AGGRESSION 
Lesion Nl 
None 5 
NSB Small 5 
NSB Large 5 
MFB Small 5 
NSB Large 
+ 2 
Apomorphine 
Aggressive ~esponse/Hour 
(mean - S.E.l 
Rearing 
Attacks (secs) Vocalizations 
+ + + 29 - 3 3013 - 241 2091 - 128 
+ + + 24 8 771 - 201* 477 - 116* 
"'- ± + 1 - O* 18 6* 26 8* 
22 + 12 1524 ± 621 588 ± 229* -
+ + + 47 5* 1209 - 200 702 - 29 
All lesions were made at 48 hours of withdrawal. Tests were 
performed 24 hours later. NSB designates nigro-striatal 
bundle, MFB designates medial forebrain bundle. Small means 
1 mA of current was passed through electrode for 15 seconds, 
large means 2 mA for 30 seconds. 
* Significantly different (p(0.05) from normal rats 
(Tukey Test). 
1 
Number of groups tested (4 rats per group). 
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TABLE 17 
EFFECT OF DEXETIMIDE ON HALOPERIDOL INDUCED BLOCKADE 
OF MORPHINE WITHDRAWAL AGGRESSION 
Aggressive Responses/Hour 
~mean ± S.E.2 
Dose Rearing 
Drug 1 mg/Kg N2 Attacks (secs) Vocalizations 
72 hour withdrawal3 
Saline 5 30 ± 2 3114 + 121 1507 + 
0.64 0 + 2 4 + Haloperidol 5 2 - -
Haloperidol 0.64 + + + 
+ 9 4 - 4 334 - 296 284 -
Dexetimide 5 
7 day withdrawal 3 
30 ± + 2387 + Apomorphine 1. 25 6 6 3391 89 -
Apomorphine 1. 25 
+ 3 0 0 0 
Haloperidol 0.64 
Apomorphine 1. 25 + + + 
+ 3 42 - 5 2792 - 533 1948 -
Dexetimide 5 
Apomorphine 1.25 
+ + + Dexetimide 5 4 1 4 - 4 8 -
+ 
Haloperidol 0.64 
1 Haloperidol was injected two hours before testing while 
dexetimide and apomorphine were injected 40 minutes and 
10 minutes, respectively, before testing. 
2 Number of groups (four rats per group) tested. 
3 Time since last morphine injection. 
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aggression. 
b) Effect of Acetylcholine 
In order to further test the similarities between mor-
phine withdrawal aggression and apomorphine-induced aggres-
sion, the effect of cholinergic stimulation and blockade was 
tested. The cholinergic agonist, pilocarpine, reduced the 
72 hour morphine w~thdrawal aggression in a dose-dependent 
manner (Figure 4), with the 10 mg/kg dose being maximally 
effective in reducing all three measures of aggression. The 
anticholinergic, dexetimide, produced a dose-dependent in-
crease in the aggression (Table 18) with the 10 mg/kg dose 
being effective. Similar results were noted in apomorphine-
induced aggression. 
c) Effect of Clonidine 
Clonidine, at a dose of 0.25 mg/kg, intensified the 
aggression normally seen at 72 hours of withdrawal (Table 
19) . Clonidine produced a similar enhancement of apomorph-
ine-induced aggression, suggesting that noradrenergic acti-
vity may be important in the aggression. 
2) ELICITED WITHDRAWAL AGGRESSION 
Naloxone, a narcotic- antagonist, is capable of pre-
cipitating a withdrawal syndrome if administered to depen-
dent rats within a few hours of a narcotic(Wei et al., 1973), 
--
but certain characteristics of the withdrawal differ from 
spontaneous withdrawal (see Gianutsos ~al., 1975). It 
Fig. 4--Dose related reduction of 72 hour 
morphine withdrawal aggression by pilocarpine. 
Pilocarpine or saline was injected into groups 
of four morphine withdrawn rats 10 minutes prior 
to observations. 
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TABLE 18 
EFFECT OF DEXETIMIDE ON 72 HOUR MORPHINE 
WITHDRAWAL AGGRESSION 
Aggressive Responses/Hour 
(mean ± S.E.) 
1 Dexetimide 2 Rearing (mg/Kg) N Attacks (secs) Vocalizations 
+ + 0 5 22 7 1515 875 1117 
5 3 22 + 9 1870 + 1009 1221 - -
10 4 57 + 8* 2891 + 641 2098 - -
* Significantly different (p<.05) from saline control 
(Omg/Kg) by (Tukey (b) Test). 
1 Dexetimide was injected 35 minutes before grouping. 
3 Number of groups (4 rats/group) tested. 
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+ 406 
+ 570 -
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TABLE 19 
EFFECT OF CLONIDINE ON MORPHINE-WITHDRAWAL AGGRESSION 1 
Aggressive Responses/Hour 
{mean ± S.E.2 
2 Rearing Drug N Attacks (secs) Vocalizations 
+ + + Saline 4 13 4 861 - 311 352 - 205 
Clonidine 3 + 4* + 253* + 6 37 1808 - 723 - 67 
* Significantly different (p(0.05) from saline 
(Student's t test). 
1 72 hours after last morphine injection. 
2 Number of groups (four rats/group) tested. 
3 Clonidine was injected at a dose of 0.25mg/Kg 30 minutes 
before observations. 
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was decided to investigate whether naloxone could likewise 
precipitate aggression in dependent rats. When administered 
to morphine-dependent rats four hours after their terminal 
dose of morphine, 4 mg/kg of naloxone abruptly precipitated 
signs of withdrawal as described in Table 20. Most notable 
were diarrhea, a loss in body weight and a profound hypo-
thermia. Dependent rats given saline or apomorphine at this 
time showed no signs of withdrawal except for a mild hypo-
thermia following apomo~phine (Table 20). When rats treated 
with naloxone were grouped, they failed to consistently 
show aggression even when a higher dose of naloxone (8 
mg/kg) was used as illustrated in Table 21. In contrast, 
when these rats were injected with a small dose of apomor-
phine (1.25 mg/kg) either alone or in combination with nal-
oxone four hours after their last morp~ine injection, they 
exhibited considerable aggression (Table 21). Amphetamine 
likewise produced some aggression, either alone or when 
combined with naloxone (Table 21). In order to control for 
a possible direct anti-aggression action of naloxone, the 
drug was administered to 72 hour morphine-withdrawn rats. 
As can be seen from the data in Table 22, naloxone failed 
to affect either the spontaneous 72 hour withdrawal aggres-
sion or the p::>tentiation of aggression produced by apomorph-
ine. These data provide further evidence for a latent super-
sensitivity of dopamine receptors as a result of narcotic 
dependence. 
r I 
TABLE 20 
PRECIPITATED NARCOTIC WITHDRAWAL FOUR HOURS 
AFTER TERMINAL MORPHINE INJECTION 
Occurence 1 
Symptom No Drug 2 (12) 2 Naloxone (16) Apomorphine2 (7) 
Diarrhea 1/12 15/16** 0/7 
Teeth Chattering 0/12 11/16** 0/7 
Weight Change (g)3 +8.0 + 1.6 -4.9 ± 1.6 +7.4 + 1. 2 
+ + + Temperature 1.26 0.11 4.95 - 0.49* 2.41 0.23* 
Reduction (deg) 4 
0.2 + 0.1 3.0 + 0.6* 0.3 + 0.2 Wet Shakes -
+ + + Ptosis 5.0 5.0 550.0 - 138.0* 45.0 - 36.0 
+ + + Writhes 0.1 - 0.1 0.3 0.2 0 0 
*Significantly different from no drug (Student's t Test). 
** Significantly different from no drugs (Chi Square) 
1 Mean± S.E. or frequency of occurence out of total 
number observed. 
2 Saline, naloxone (4mg/Kg) or apomorphine (l.25mg/Kg) 
injected 4 hours after terminal dose of morphine 
(135mg/Kg). Observations made for 30 min., 10 minutes 
after injection. Number in ( ) denotes number of 
animals observed. 
3 Change in body weight from weight immediately prior to 
last morphine injection. 
4 Fall in body temperature from hyperthermia seen one hour 
after last morphine injection. 
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TABLE 21 
ELICITATION OF WITHDRAWAL AGGRESSION IN MORPHINE DEPENDENT 
RATS FOUR HOURS AFTER MORPHINE INJECTION 
Respons$s/Hour 
(mean - S.E.) 
Dose 
N2 
Rearing 
Drug 1 {mg/Kg} Attacks {secs} Vocalizations 
None 3 0 2 + 2 0 
Naloxone 4 8 0 3 + 2· 130 ± 48 -
8 9 4 + 3 77 + 50 237 + - - 69 
+ + + Apomorphine 1. 25 4 46 - 12 2472 - 558 1233 - 189 
+ + + Amphetamine 2 8 7 3 1347 - 496 423 - 187 
4 4 0 3 ± 3 42 + 29 -
Naloxone 4 + + + 
+ 4 60 - 14 2896 - 167 2162 - 109 
Apomorphine 1. 25 
Naloxone 8 + + + 
+ 4 40 - 9 2326 - 365 1793 - 236 
Apomorphine 1.25 
Naloxone 4 + + + 
+ 4 16 - 4 978 - 306 1359 - 460 
Amphetamine 2 
1 
Drugs injected 4 hours after last morphine injection (135mg/ 
Kg). Apomorphine was injected 5 minutes, while naloxone 
was injected 10 minutes before observation. Amphetamine 
was injected 60 minutes prior to testing. 
2 
Number of groups tested (4 rats/group) . 
~ 
I 
j 
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TABLE 22 
EFFECT OF APOMORPHINE OR NALOXONE ON 72 HOUR 
MORPHINE WITHDRAWAL AGGRESSION 
Responsi/Hour 
(mean - S. E.) 
Rearing 
Jc 
2 
Drug 
Dose 
(mg/Kg) Attacks (secs) V.uc-a:Ti za tions 
None 6 30 + 4 3296 + 185 ra:rrg + I.:95 
Apomorphine 1.25 7 87 + 5 3324 + 210 I.~9--S: +- 3..TT -
Naloxone 4 5 42 + 5 3474 ± 94 2T4-.T +- IlS -
8 6 28 + 3 2294 + 248 I.S:6:Z +- 222.. - -
Apomorphine 1. 25 
+ + + + 2 75 - 2 3409 90 I.ff3:8' 35:5 
Naloxone 4 
1 Number of group tested (4 rats/group)~ 
2 Apomorphine was injected 5 minutes before testirrg whi:Ia 
naloxone was injected 10 minutes before testing. 
Injections were made 72 hours after last morphine 
injection. 
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3) frotracted Aggres~ion 
rt is known that some of the signs of narcotic abstin-. 
ence can oe detected even weeks or months after witlidrawal. 
in rats (Martin and Sloan, 1971) and humans (Himmelsoach, 
1941), a phenomenon known as protracted abstinence. There-
fore, it was of interest to determine if aggression would 
likewise be present during protracted abstinence. Rats were 
made dependent on morphine and allowed to undergo contin-
uous withdrawal for 30 days. When grouped, these rats ex-
hibited aggression as shown in Table 23. The aggression 
was markedly enhanced by apomorphine (1.25 mg/kg), a nor-
mally ineffective dose, and blocked by a small dose of 
morphine (10 mg/kg) (Table 23). A large (2 mA, 30 sec) 
lesion of the nigro-stri&tal bundle produced 24 hours 
before testing completely blocked the aggression. When the 
effect of the lesion was bypassed by stimulating the post-
synaptic receptors with apomorphine, the aggression was 
reinstated (Table 23). Lesions of the adjacent medial fore-
brain bundle, which carries noradrenergic and serotonergic 
fibers, did not significantly affect the aggression. These 
results suggest that the dopaminergic supersensitivlty which 
develops during morphine dependence is a long lasting phen-
omenon. 
TABLE 23 
EFFECT OF APOMORPHINE AND BRAIN LESIONS ON 
MORPHINE-WITHDRAWAL AGGRESSION. 
Aggressive ~espouses/Hour 
(mean - S.E.) 
Nl 
Rearing 
Treatment Attacks/Bites (secs) Vocalizations 
ISOLATED CONTROLS 2 
+ + + No Drug 6 1 
-
0.3 52 48 4 - 2 
Apomorphine3 4 + + 0 9 - 9 14 - 3 
72 HOUR MORPHINE WITHDRAWAL 
+ + + No Drug 3 26 - 6 3599 - 1 2191 - 271 
30 DAY MORPHINE WITHDRAWAL 
No Drug 6 23 + 9 1513 + 280 828 + 260 - - -
Morphine 4 2 0 0 0 
Apomorphine 3 + + + 5 56 - 10 3017 138 1961 150 
5 + 1423 + + MFB Lesion 3 33 - 5 - 298 753 59 
± + + NSB Lesion 7 1 1 39 - 39 18 - 6 
NSB Lesion 5 
+ 4 42 + 22 625 + 267 528 + 222 - -
Apomorphine3 
1 Number of groups (4 rats/group) tested. 
2 Rats housed one per cage for 30 days. 
3 1. 25 mg/Kg 
4 10 mg/Kg, 30 minutes prior to testing. 
5 
.Lesions were produced 24 hours before testing. MFB denotes 
medial forebrain bundle and NSB denotes nigrostriatal 
bundle. 
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C. Chronic Haloperidol 
If it is assumed that morphine-withdrawal aggression 
reflects a dopaminergic supersensitivity produced as a re-
sult of dopamine receptor Blockade by morphine, then cer-
tain similarities should Be noted between chronic morphine 
and chronic haloperidol, since haloperidol is generally re-
garded to block dopamine receptors (Carlsson and Lindqvist, 
1963; Anden ~al., 1270a). ~or this reason, haloperidol 
was administered to rats chronically and observations were 
made after the drug was discontinued. 
Following the cessation of chronic treatment with hal-
operidol, rats exhibited an apparent supersensitivity to the 
stereotypy-producing actions of apomorphine (Table 24) or 
amphetamine (Table 25). It is widely believed that stereo-
typy produced by these drugs is dependent upon dopaminergic 
stimulation (Ernst, 1967; Snyder~ al., 1970). Doses of 
apomorphine (1.25 mg/kg) and amphetamine (7.5 mg/kg) were 
selected which produced a low to moderate degree of ster-
eotypy in normal rats on the basis of pilot experiments. 
When these drugs were administered to rats three days after 
stopping chronic treatment with haloperidol, the stereotypy 
was significantly increased. When the rats treated chron-
ically with haloperidol were grouped after discontinuation 
of the drug, no spontaneous aggression was observed (Table 
26). However, when these rats received small doses of 
apomorphine {0.63-2.5 mg/kg), considerable aggression was 
~--------~~---~~ 
TABLE 24 
APOMORPHINE 1 INDUCED STEREOTYPY IN RATS AFTER CHRONIC 
TREATMENT WITH HALOPERIDOL 
Group 
2 Control 
Chronic 3 Haloperidol 
N 
16 
18 
Stereotypy Score 
(Median+ S. E.) 
7 + 1. 3 
12 + 1.3* 
* Significantly different (p < 0. 025) from control 
(Mann-Whitney U-Test). 
1 1.25 mg/kg, 10 minutes before testing. 
2 Naive rats. 
3 72 hours after last haloperidol injection. 
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TABLE 25 
AMPHETAMINE! INDUCED STEREOTYPY IN RATS AFTER CHRONIC 
TREATMENT WITH HALOPERIDOL 
Group 
2 Control 
Chronic 3 Haloperidol 
* 
N 
16 
10 
Stereotypy Score 
(Median+ S. E.) 
8 + 0.7 
14 + 1.4* 
Signific a ntly different {p<._0.05) from control (Mann-
Whitney U Test). 
1 7.5 mg/kg, 30 minutes before observations 
2 Naive rats. 
3 72 hours after last haloperidol injection. 
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TABLE 26 
APOMORPHINE INDUCED AGGRESSION FOLLOWING CHRONIC HALOPERIDOL ADMINISTRATION 
Days of Aggressive Responses/Hour 
Dose With- (mean+ S. E .) 
Drug (mg/kg) drawal 1 N2 Attacks Rearing Vocalizations 
Isolated Controls3 
Saline - - 4 0 0 0 
Apomorphine 2.5 - 4 1 + 1 22 + 22 19 + 3 
...... 
. 0 
Chronic Haloperidol4 0 
Saline 
-
3 5 0 7 ± 7 4 + 4 
Apomorphine 1. 25 2 3 0 0 0 
I 
2.5 2 2 13 + 10 16 06 ±. 14 7 5 895 + 830 
1. 25 3 3 1 + 1 17 ± 17 6 + 6 
2.5 3 8 59 ± 13 1734 ± 303 1359 + 310 
0.64 7 3 6 + 3 678 ± 340 440 ± 259 
1. 25 7 3 22 + 6 2668 ± 349 1730 + 666 
2.5 7 4 78 ± 17 2747 + 154 1951 + 313 
2.5 18 4 8 + 8 528 + 512 312 + 310 
TABLE 26 continued 
1 Refers to number of days after terminal injection of haloperidol. 
2 Number of groups tested (3 rats per group). 
3 Housed one per cage for three weeks. 
4 Animals injected chronically with haloperidol as described in Methods. 
..... 
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observed (Table 26). This indicated that rats who exhibit 
dopaminergic supersensitivity, exhibit a supersensitivity 
to the aggression eliciting effects of apomorphine as well, 
which would be consistent with the explanation proposed in 
morphine withdrawal. However, in contrast to morphine-with-
drawal aggression, there was no spontaneous aggression after 
chronic haloperidol. The aggression produced by apomorphine 
was particularly intense seven days after "withdrawal" but 
had subsided by 18 days (Table 26). If amphetamine was in-
jected instead of apomorphine, aggression was observ~d in-
frequently and inconsistently (Table 27), in contrast to the 
effect seen during morphine withdrawal. There was virtually 
no aggression even with a dose of amphetamine as high as 
16 mg/kg. 
Despite the fact that aggression was not elicited by 
amphetamine in rats after chronic haloperidol, the locomo-
tor stimulation produced by amphetamine was increased. It 
can be seen in Figure 5 that a normally ineffective dose of 
amphetamine (0.2 mg/kg) produced a significant stimulation 
of locomotor activity after chronic treatment with haloper-
idol. This effect of amphetamine was further analyzed in 
Figure 6. It should be noted, first of all, that rats which 
had been treated with haloperidol chronically exhibited an 
increased spontaneous activity after drug administration was 
discontinued when compared with drug-free rats. (This was 
also noted when chronically haloperidol treated rats were 
compared with rats treated chronically with 0.3% tartaric 
TABLE 27 
FAILURE OF AMPHETAMINE TO INDUCE AGGRESSION IN RATS CHRONICALLY TREATED 
WITH HALOPERIDOL 
Drug 
Saline 
cl-amphetamine 
!-amphetamine 
d-ampheta1'line 
!-amphetamine 
apomorphine 
Days of 
Dose With-
(mg/kg) drawa1 1 
- 3 
4 3 
8 
16 
8 3 
16 
8 7 
16 
8 7 
16 
2.5 7 
N2 
4 
3 
5 
1 
3 
2 
2 
2 
2 
2 
3 
Aggressive Responses/Hour 
(mean + S.E.) 
Attacks Rearing Vocalizations 
0 0 0 
0 0 0 
2 + 2 72 + 72 69 + 44 
0 0 5 
5 + 5 772 + 772 96 + 90 
2 + 1 84 + 62 65 + 18 
0 0 0 
0 0 0 
0 0 6 + 6 
0 0 8 + 6 
72 + 19 3016 + 341 1801 + 295 
..... 
0 
\;J 
... 
TABLE 27 continued 
1 Refers to days since last haloperidol injection. 
2 Number of groups tested (3 rats per group). 
3 Amphetamines were injected 30 minutes prior to observations. Apomorphine was 
injected 5 minutes before testing. 
...... 
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Fig. 5--Effect of amphetamine on locomotor 
activity in normal and chronic haloperidol treated 
rats. Amphetamine was injected, at the indicated 
doses, to normal rats and to rats who had received 
their last of a series of haloperidol injections 
three to six days prior to testing. Activity was 
measured for one hour, 60 minutes after the amphet-
amine injection. Each point is the mean + S. E . 
for 10 rats. Asterisks (*) indicate that the dose 
significantly increased locomotor activity (p(0.05) 
compared with the corresponding saline (O mg/kg) 
control (Dunnet's Test, Winer, 1971). 
1500 
... 
w 
• (/) 1200 
+• 
z 
<( 
w 
~ 
900 
.. 
.£::. 
.......... 
en 
I-
z 
::::> 600 0 (.) 
>- CHRONIC HALOPERIDOL I-
-> -<>- NOR~'1AL 
- 300 . I-(.) 
<( 
0 -....,..__,,~' --, ---1 ---, 
0 0.10 0.20 0.40 
AMPHETAMINE (mg/kg) 
i+:ilV ,., 
Fig. 6--Effect of amphetamine, apomorphine 
or alpha-methyl-p-tyrosine (MPT) on locomotor ac-
tivity in normal and chronically haloperidol treat-
ed rats. The rats were chronically treated with 
haloperidol, then withdrawn for three to five 
days before locomotor activity testing. Ampheta-
mine (1.6 mg/kg) was injected 60 minutes before 
testing, while apomorphine (0.5 mg/kg) was injected 
10 minutes before testing. MPT was injected either 
4 hours or 4 and 16 hours before testing. Locomo-
tor activity in haloperidol treated rats was sig-
nificantly higher than control rats in each compar-
ison (p<,0.01). MPT significantly reduced locomo-
tor activity in all groups (MPT vs. no MPT, p<0.01). 
After MPT treatment, amphetamine induced locomotor 
stimulation was not higher than the control activity 
of normal rats, but was significantly higher (p(0.01) 
in haloperidol treated rats, except when these rats 
were given two doses of MPT (stripped bars). Apo-
morphine failed to increase locomotor activity in 
normal rats (p>0.05), but did produce stimulation 
in the chronic haloperidol group (p< 0.05). 
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acid, the vehicle for haloperidol, in pilot experiments.) 
In addition, they exhibited an enhanced response to the stim-
ulation produced by apomorphine and to the maximally effec-
tive dose of amphetamine (1.6 mg/kg). When alpha-methyl-p-
tyrosine (MPT) was administered (200 mg/kg, four hours be-
fore testing), it reduced the spontaneous locomotor activity 
and blocked the stimulation produced by amphetamine in nor-
mal rats (Figure 6). However, amphetamine was still capable 
of producing a marked stimulation after MPT in the chronic 
haloperidol group, and only a very large dose of MPT (two 
doses of 200 mg/kg each, 12 hours apart) was capable of 
blocking the amphetamine in these rats. Thes~ results fur-
ther support the idea of a dopaminergic supersensitivity 
after chronic haloperidol. 
The influence of drugs having an effect on acetylcholine 
was also studied. Dexetimide was more effective in producing 
locomotor stimulation following chronic haloperidol. As 
shown in Figure 7, normally ineffective doses of dexetimide 
produced a significant increase in locomotor activity when 
tested four t~ six days after termination of repeated halo-
peridol treatment. In contrast, pilocarpine was less effec-
tive in reducing locomotor activity after chronic haloperi-
dol as illustrated in Figure 8. Pilocarpine normally de-
presses activity at a dose of 4 mg/kg, but this dose did not 
reduce activity in the chronic haloperidol group. These 
results are suggestive of a cholinergic hyposensitivity 
after chronic haloperidol. Pentobarbital was equally 
~""""~-~.--------- -
Fig. 7--Effect of dexetimide on locomotor 
activity in normal and chronic haloperidol treated 
rats. Dexetimide was injected at the indicated 
doses into normal rats and to rats who had received 
their last of a series of haloperidol in~ections 
three to six days before testing. Activity was 
measured for one hour, 30 minutes after injection. 
Asterisks (*) indicate that the dose significantly 
increased (p"-0.05) locomotor activity compared 
with the corresponding saline (O mg/kg) cont~ol 
group (Dunnet's Test, Winer, 1971). 
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Fig. 8--Effect of pilocarpine on locomotor 
activity in normal and chronic haloperidol treated 
rats. Pilocarpine was injected at the indicated 
doses to normal rats and to rats who had received 
their last of a series of haloperidol injections 
three to six days before testing. Activity was 
measured for one hour, ten minutes after the in-
jection. Asterisks {*) indicate that the dose sig-
nificantly (p 0.05) decreased locomotor activity 
compared with the corresponding saline (O mg/kg) 
control group (Dunnet's Test, Winer, 1971). 
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effective in both normal ari.d haloperidol "withdrawn" rats 
(Table 28). 
Lastly, the dynamics of striatal dopamine were directly 
measured following termination of chronic treatment with hal-
operidol, in order to determine if neurochemical substantia-
tion for the dapaminergic supersensitivity could be obtained. 
It can be seen from Table 29 that neither the steady state 
level nor the turnover of striatal dopamine differed in the 
chronic haloperidol group when compared with naive rats. 
However, doses of apomorphine which produced no change in 
dopamine turnover in normal rats, significantly reduced stri-
atal dopamine turnover when given seven days after the ter-
minal dose of haloperidol (Figure 9), supporting a concept 
of dopaminergic supersensitivity. 
TABLE 28 
EFFECT OF PENTOBARBITAL ON LOCOMOTOR ACTIVITY IN 
RATS AFTER CHRONIC TREATMENT WITH HALOPERIDOL 
Group 
2 Control 
N 
5 
LOCOMOTOR ACTIVITY COUNTS/HOUR 
(Mean+ S. E.) 1_ Saline Pentobarbital 
690 + 68 432 + 48 * 
Chronic Haloperidol 3 5 891 + 66 656 + 82 * 
* Significantly different (p < 0. 05) from corresponding sal-
ine control (Student's t test). 
1 Pentobarbital (10 mg/kg) was inkected 10 minutes before 
testing. 
2 Naive rats. 
3 Three to six days after last haloperidol injection. 
TABLE 29 
EFFECT OF CHRONIC HALOPERIDOL TREATMENT ON STRIATAL 
DOPAMINE 
CONTROLS 1 
CHRONIC 
HALOPERIDOL2 
Striatal Dopamine Level 43.7 + 2.7 39.9 + 4.8 
(nmol/gram) 
Dopamine Turnover 11. 7 + 1. 3 12.3 + 1. 7 
(nmol/g/hour) 
Values are mean and standard error based upon four animals 
used in each group. There was no difference (p 0.05) be-
tween controls and chronic haloperidol groups on either 
measure (Student's t test). 
1 Naive rats. 
2 Rats treated chronically with haloperidol and then left 
drug free for seven days before testing. 
, 1 ? 
Fig. 9--Effect of apomorphine on striatal 
dopamine turnover in normal rats and after chronic 
haloperidol. Rats were sacrificed 30 minutes after 
apomorphine or saline. The drugs were injected into 
either normal rats or rats who had received haloper-
idol for 17 days. Tests were made seven days after 
the last haloperidol injection. The dose of 0.63 
mg/kg significantly reduced the striatal dopamine 
turnover in the chronic haloperidol group (p~0.05) 
while the dose of 2.5 mg/kg was the minimum ef-
fective dose in normal rats. ~oints are mean + 
S. K. for four rats. Dunnet's Test was used for 
statistical evaluations. 
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V. DISCUSSION 
The discussion of the results will be divided into the 
same three sections used in the results (i.e., apomorphine-
induced aggression, morphine withdrawal aggression, chronic 
haloperidol) examining the role of the various neurotrans-
mitters in the behavior. In addition, there will be a sec-
tion which will specifically compare haloperidol with mor-
phine. 
In brief, the postulated mechanisms behind drug-induced 
aggression may be summarized as shown in Table 30. Dopamine 
plays a major role in the initiation and maintenance of the 
behavior, with acetylcholine and serotonin having an antag-
onistic effect. Stimulation by norepinephrine appears to 
facillitate the aggression, but further experimentation is 
necessary to clearly establish this effect. In general, 
apomorphine-induced aggression and morphine-withdrawal ag-
gression appear to operate under the same mechanisms. 
During morphine withdrawal, there is spontaneous and 
amphetamine stimulated aggression in contrast to the be-
haviors noted after chronic haloperidol, despite the fact 
that after either treatment there is evidence of dopaminer-
gic supersensitivity. Several possibilities for this ap-
parent contradiction will be discussed. In brief, these 
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TABLE 30 
EFFECT OF BRAIN NEUROTRANSMITTERS IN DRUG INDUCED 
AGGRESSION 
Transmitter 
DOPAMINE 
ACETYLCHOLINE 
SEROTONIN 
NOREPINEPHRINE 
TYPE OF AGGRESSION 
Apomorphine 
Induced 
* 
+ ? 
Morphine 
Withdrawal 
* 
+ ? 
* This type of stimulation is necessary for aggression to 
occur. 
- This type of stimulation opposes dopamine effect. 
+ This type of stimulation facillitates dopamine effect. 
? Evidence is insufficient to make a decision or contra-
dictory. 
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explanations are that chronic haloperidol may lead to an 
inhibition of neurotransmitter release in selected brain 
areas; the supersensitivity after each drug may be qual-
itatively or quantitatively different; morphine may direct-
ly interfere with compensatory mechanisms to alter the nor-
mal balance in brain functio~; or any combination of these 
effects. 
A. Apomorphine-Induced Aggression 
1) Role of Dopamine 
Apomorphine induced aggression in a dose-dependent 
manner. This was reliably established using three different 
parameters of aggression. It is generally accepted that apo-
morphine stimulates dopamine (DA) receptors on the basis of 
biochemical (Anden ~al., 1967), histochemical (Anden ~ ~·, 
1967), behavioral (Ernst, 1967) and neuroanatomical (Price 
and Fibiger, 1974) studies. In addition, large doses of 
apomorphine have pre-synaptic actions on dopamine neurons, 
causing both an inhibition of DA uptake and a dose-dependent 
release (Ferris~ ,!l., 1974). 
These mechanisms may be considered to be responsible for 
the aggression produced by apomorphine, since it was found 
that che aggression was blocked by neuroleptics, drugs which 
are believed to block DA receptors with little if any direct 
effect on norepinephrine (Nyback ~al., 1968; Anden ~al., 
1970a). In addition the aggression was shown to be intensi-
fied by amphetamine. Previous reports have also shown that 
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the aggression produced by apomorphine plus reserpine is 
increased by intraventricular dopamine (Patni and Dandiya, 
1974). 
Evidence for a dopaminergic basis for drug-induced ag-
gression is also supported by several reports in the liter-
ature. For example, the aggression in mice elicited by am-
phetamine is blocked by neuroleptics while drugs which inhi-
bit the synthesis of norepinephrine (NE), such as FLA-63, or 
block NE receptors, such as phenoxybenzamine do not have a 
clear-cut blocking action (Hasselager £.!_al., 1972). Simil-
arly, fighting was observed in rats after treatment with 
DOPA plus reserpine and a peripheral decarboxylase inhibitor, 
which produced a substantial elevation of brain DA (Benkert 
~al., 1973a). Elevation of brain NE levels with pargyline 
plus dihydroxyphenylserine failed to produce fighting (Ben-
kert£.!_ al., 1973a). In addition, the aggression produced 
by ET-495 was increased by L-DOPA (Butterworth£.!_ al., 1975). 
A detailed search of the literature revealed that drug-in-
duced aggression not associated with elevated DA receptor 
activity is rarely, if ever, observed. Therefore, it may be 
concluded that DA plays a primary role in drug-induced aggres-
sion. 
2) Cholinergic - Dopaminergic Interaction 
Cholinergic activity in the CNS produces a variety of 
effects on aggression, depending on the model studied. For 
example, local injection of cholinergic compounds into the 
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hypothalamus (Myers, 1964) or amydgala (Allikmets ~ .21.·, 
1969) of cats produces a rage response which includes at-
tacks on the experimenter. Similarly, anticholinergic drugs 
are potent inhibitors of isolation-induced aggression in 
mice (Janssen~ .21.·, 1960). On the ooher hand, cholinergic 
drugs suppress the hyperirritability resulting from septa! 
lesions (Stark and Henderson, 1972), while the anticholiner-
gic, scopolamine, when combined with an inhibitor of mono 
amine oxidase, res~lts in aggression-like responses in rats 
(Randrup and Munkvard, 1969). In the present experiment, 
pilocarpine blocked both the aggression which occurs during 
morphine withdrawal and the aggression induced by injections 
of apomorphine, while dexetimide, an anticholinergic comp-
ound (Janssen~ al., 1971) devoid of serotonergic or nor-
adrenergic blocking properties (Janssen, 1971) enhanced both 
forms of aggression. Furthermore, moderately effective doses 
of oxyperomide and pilocarpine were synergistic. These re-
sults would argue that the effect of cholinergic stimulation 
in drug-induced aggression is antagonistic to dopaminergic 
stimulation. The blockade of aggression by pilocarpine ap-
peared to be centrally mediated since it was partially re-
versed by anticholinergic drugs having a central action but 
was unaffected by the peripherally acting anticholinergic 
isopropamide (Janssen and Niemegeers, 1967) at a dose which . 
blocked the pilocarpine-induced diarrhea. 
The extensive evidence for a balance between acetylcho-
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line and dopamine in the CNS (see ·Section II.C.l) suggests 
an explanation for the apparent paradoxical effects of chol-
inergic stimulation on aggression. Acetylcholine (ACh) has 
a widespread distribution in the CNS and it may be possible 
that activity in certain brain areas enhances, while activity 
in other brain areas reduces aggression. It is interesting 
in this regard that . cholinergic drugs injected into the cen-
tral nucleus of the amygdala suppress the rage response pro-
duced by cholinergic stimulation of the hypothalamus (Decsi 
~al., 1969). It is possible that the proposed cholinergic 
inhibitory system directly interacts with a dopaminergic sys-
tem which initiates the aggressive responding~ Therefore, 
aggression elicited by DA hyperactivity - as a result of apo-
~orphine injection or morphine withdrawal - is modulated by 
the activation of a cholinergic inhibitory system in a man-
ner analogous to the control of motor movements proposed by 
Klawans (1968). Pilocarpine would synergize with this chol-
inergic system, while dexetimide would antagonize it. It 
should be remembered from Section II.C.l that many other be-
haviors produced as a result of DA stimulation are antagon-
ized by ACh, such as stereotypy and locomotor stimulation 
(Mennear, 1965; Arnfred and Randrup, 1968; Klawans ~ ~., 
1970) while the locomotor stimulation produ~ed by antichol-
inergics is dependent on DA (Thornburg and Moore, 1973b). 
However, neurochemical support for this hypothesis is lack-
ing. Dopaminergic drugs reduce the release of ACh in the 
striatum (Sethy and Van Woert, 1974) while anticholinergics 
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reduce the utilization of DA (O'Keefe ~al., 1970; Haubrich 
and Goldberg, 1975). It would be expected from the above 
hypothesis that DA stimulation should facilitate the release 
of ACh. It should be pointed out that the neurochemical an-
anyses were made only in the striatum, which may not be the 
area responsible for aggression. Interestingly, amphetamine 
causes an increase in ACh output from the cortex, which is 
prevented by alpha-methyl-p-tyrosine (Nistri ~al., 1972). 
Alternatively, it may be hypothesized that the reduced ACh 
as a result of DA stimulation is the mechanism which trig-
gers the aggression, or that still other interactions are 
necessary. 
In addition to the effects enumerated above, low doses 
of anticholinergic drugs were also able to partially reverse 
the blockade of aggression produced by the neuroleptics but 
not the blockade produced by morphine. Anticholinergics al-
so reverse the increase in dopamine turnover produced by the 
neuroleptics (Anden, 1972) as well as some of the anti-psy-
chotic activity of these drugs (Singh and Smith, 1973). 
3) Dopaminergic-Serotonergic Interaction 
Evidence in favor of a serotonergic system which antag-
onizes aggression was also provided by this study. It was 
predicted that amphetamine, which releases dopamine (Besson 
et al., 1971; Chiueh and Moore, 1973), would intensify apo-
morphine induced aggression. Although amphetamine did in-
crease the aggression occuring after threshold doses of apo-
morphine, no aggression was elicited by the combination of 
amphetamine and sub-threshold doses of apomorphine. It 
should be remembered that release of serotonin by amphet-
amine reduced the locomotor stimulation produced by the drug 
(Breese g al., 1974). It was demonstrated that the combina-
tion of amphetamine . plus cyproheptadine, a serotonin recep~ 
tor blocker, and a sub-threshold dose of apomorphine did re-
sult in significant aggression, while cyproheptadinc at the 
dose used had no effect of its own. This suggests that sero-
tonin release antagonizes aggr~ssion. However, cyprohepta-
dine is non-specific in its effect, since it is anticholin-
ergic and antihistaminic in addition to being anti-seroton-
ergic and these other effects would have to be ruled out be-
fore making a definite conclusion. 
An additional test of this hypothesis utilized p-chloro-
amphetamine (PCA) which produces a long-lasting depletion of 
brain serotonin (Sanders-Bush ~ al., 1972). This drug pro-
duced a marked reduction in the threshold dose of apomorphine 
necessary for eliciting aggression. Recent evidence (Yunger 
~al., 1974) suggests that large doses of PCA cause a de-
generation of substantia nigra cells, so that it may be in-
terpreted that the apomorphine effect is due to a dopamin-
ergic denervation supersensitivity after PCA. Alternatively, 
it may be hypothesized that PCA causes reduced activity in 
a serotonin-containing inhibitory system and therefore re-
moves an inhibition of dopaminergic activity. Consistent 
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with the latter interpretation are studies which show that 
parachlorophenylalanine (PCPA), an inhibitor of serotonin 
biosynthesis (Koe and Weissman, 1966), elicits aggression 
after treatment with DOPA in mice (Lycke ~ ~·, 1969) and 
rats (Benkert~~·, 1973b). Furthermore, three days af-
ter an injection of 20 mg/kg of PCA, there is spontaneous 
aggression in mice (Gianutsos and Lal, 1975). 
Apomorphine causes a transient elevation in serotonin 
turnover which is antagonized by neuroleptics (Grabowska ~ 
al., 1973). Furthermore, activity in the dopaminergic caput 
nuclei caudati rostromedialis of the caudate nucleus is abol-
ished by activation of serotonergic nuclei in the caudate 
(Cools, 1974). These results suggest that dopaminergic ac-
tivity activates a serotonergic system which attenuates the 
effects of the dopaminergic stimulation that initiated the 
cycle. 
In addition, the disruption of behavior produced by 
scopolamine is antagonized by elevating brain serotonin with 
5-hydroxytryptamine (Swonger and Rech, 1972), while pilo-
carpine increases brain serotonin turnover (Haubrich and 
Reid, 1972). These findings suggest a co-operation between 
ACh and serotonin in the CNS. Since both neurotransmitters 
appear to reduce drug-induced aggression, such a co-opera-
tive relationship would be consistent with the data presen-
ted. 
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4) Effect of Clonidine 
Clonidine dose-dependently and reliably elicited ag-
gression when combined with a sub-threshold dose of apo-
morphine. It was previously reported that a very high 
dose of clonidine (1 mg/kg) could induce some aggression 
in rats after apomorphine or ET-495 (Senault, 1974), 
while a smaller dose (0.2 mg/kg) increased the "ferocity" 
and motor activity of rats produced by ET-495 while inhibi-
ting the stereotypy (Butterworth et al., 1975). The pre-
sent results confirmed and extended the subjective impressions 
gained by these fixed dose experiments. 
elf, did not produce aggression in rats. 
Clonidine, by its-
Clonidine is considered to be a centrally acting nor-
adrenergic stimulant since it decreases the rate of deple-
tion of norepinephrine in the brain after alpha-methyl-p-
tyrosine (Anden et .2..1·, 1970b). This effect was measured 
both biochemically and histochemically. However, clonidine 
in vitro is also reported to inhibit the stimulation in-
duced release of norepinephrine from brain slices (Starke 
and Mentel, 1973) and block the increase in cyclic AMP 
formation by norepinephrine (Vetulani ~al., 1975), which 
suggests that clonidine may have an anti-adrenergic effect. 
Similarly, clonidine in low doses decreased the self-stim-
ulation of the medial forebrain bundle, which is usually 
enhanced by norepinephrine (Vetulani et al., 1975). Cloni-
dine does not affect the turnover of dopamine in the stri-
atum (Anden et al., 1970b; Rochette and Bradet, 1975). 
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If it is assumed that clonidine is a noradrenergic 
agonist, it may be argued that dopaminergic activity initi-
ates noradrenergic activity (or vice versa) and that this 
combination leads to the expression of aggression. Some 
evidence which would support this notion is as follows: 
Apomorphine-induced aggression is blocked by large doses 
of the alpha-adrenergic receptor blocker, phenoxybenzamine 
(Senault, 1974) or the beta noradrenergic receptor blocker, 
L-propranolol (Butterworth~ !!l·, 1975). In mice, a very 
large dose of clonidine induces aggression by itself, but 
this aggression is blocked by haloperidol and not by p~en-
oxybenzamine. Neurochemically, apomorphine increases the 
turnover of norepinephrine, apparently by an indirect ac-
tion through stimulation of dopamine receptors (Persson 
and Waldeck, 1970). On the other hand, Geyer and Segal 
(1974) reported that intracerebral injections of dopamine 
enhance shock induced aggression, while intracerebral nor-
epinephrine reduces theaggression. Similarly, it was shown 
in REM-sleep deprived rats that aggression could be elicited 
by apomorphine, L-DOPA or phenoxybenzamine (Carlini and Lind-
sey, 1974). These latter results suggest that norepinephrine 
reduces aggression. 
An alternative explanation may be that the clonidine 
effect is mediated by serotonin. Clonidine, at a dose which 
does not affect serotonin metabolism on its own (1 mg/Kg), 
antagonized the increase in the accumulation of the serotonin 
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metabolite, 5-hydroxyindoleacetic acid produced by apo-
morphine (Maj ~ tl·, 1973). Thus, it may be argued that, 
as above, stimulation of dopamine receptors produces a com-
pensatory antagonistic activation of serotonin neurons. 
Clonidine, therefore, would exacerbate the aggression in-
duced by apomorphine by preventing the release of serotonin 
which would normally antagonize the aggression in a manner 
analogous to the arguement for PCA (above). 
B. Morphine Withdrawal Aggression 
Aggression during morphine withdrawal has been consid-
ered to reflect a dopaminergic supersensitivity in the CNS 
since it is enhanced by apomorphine (Puri and Lal, 1973a), 
amphetamine (Thor, 1969; Lal~ 2-1_., 1971) and L-DOPA (Puri 
and Lal, 1973a) and reduced by haloperidol (Puri and Lal, 
1973a). The degree of aggression was shown to be dependent 
on the amount of morphine administered during the addiction 
process, since increasing the terminal dose or the duration 
of addiction increased the amount of aggression seen during 
withdrawal. The aggression reaches its maximum intensity at 
72 hours of withdrawal, in contrast to other signs of with-
drawal which peak earlier. However, the onset of withdrawal 
hyperactivity was found to be well correlated with the ap-
pearance of the aggression. 
The aggression was reduced by morphine, haloperidol or 
lesions of the dopaminergic nigro-striatal bundle, which pro-
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vides further support for the role of dopamine in the with-
drawal aggression. The withdrawal aggression was affected 
in qualitatively the same way as apomorphine-induced aggres-
sion. It was found to be blocked by morphine, haloperidol 
or pilocarpine and increased by dexetimide, apomorpnine, 
amphetamine and clonidine, implying that the same mechanisms 
responsible for apomorpnine-induced aggression also govern 
morphine-withdrawal aggression. However, in contrast to 
these effects in naive rats, anticholinergics failed to an-
tagonize the blockade of aggression produced by neuroleptics 
in addicted rats. This will be discussed further below. 
1) Elicited Aggression 
Naloxone precipitated withdrawal in addicted rats when 
administered within a few hours of the last morphine injec-
tion, but the symptamatology had some differences from the 
withdrawal produced by witholding of morphine injections. 
In the naloxone precipitated withdrawal, there was evidence 
of teeth chattering and lacrimation which are not seen during 
spontaneous withdrawal and the naloxone treated rats showed 
more diarrhea and fewer "wet shakes" than spontaneously 
withdrawn rats (see Gianutsos ~ .21.·, 1975). In addition, 
the naloxone-treated rats failed to consistently show ag-
gression during the time in which they exhibited other signs 
of withdrawal. It should be pointed out that rats under-
going either naloxone-precipitated or spontaneous withdrawal 
are hyperirritable and will vocalize and struggle violently 
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and bite the experimenter when handled. However, when 
grouped, the naloxone treated rats did not consistently 
fight with each other. Since the onset of withdrawal ag-
gression in spontaneously withdrawn rats occurs later than 
other signs, it perhaps may be expected that aggression dur-
ing naloxone-precipitated withdrawal may occur at a later 
time as well. Furthermore, the possibility remains, as yet 
untested, that naloxone may compress the withdrawal period 
such that aggression may emerge earlier than normal after 
naloxone treatment (that is to say before 48-72 hours of 
withdrawal) but not during the time of peak drug effect. 
Naloxone's action could not be attributed to a direct anti-
aggression action since it failed to affect either the 72 
hour withdrawal aggression or the weak elicitation of ag-
gression produced by amphetamine at four hours of withdrawal. 
Rowever, it is interesting that naloxone causes an increase 
in brain dopamine levels in morphine dependent rats (Iwamoto 
~al., 1973), which is suggestive of decreased transmitter 
release. Clearly, such an effect would prevent the expres-
sion of withdrawal aggression. 
In contrast to the effect of naloxone, apomorphine ad-
ministered as little as four hours after the last morphine 
injection was capable of eliciting intense aggression in 
addicted rats without producing other signs of withdrawal. 
The aggression was produced either in the presence or ab-
sence of naloxone. These results strongly suggest that the 
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addicted rats have a latent dopaminergic supersensitivity 
which remains masked during the addiction process while mor-
phine injections are continued. Despite the fact that there 
are supersensitive DA receptors at the time of withdrawal, 
the aggression still does not emerge until 48-72 hours later. 
It is possible, although untested, that the supersensitivity 
functionally increases in intensity over the course of with-
drawal as a compensation for other withdrawal signs. It is 
interesting that directly and indirectly acting dopaminergic 
agonists reduce the severity of withdrawal, except for ag-
gression which is intensified (Gianutsos, Hynes and Lal, in 
preperation). Exactly how this may take plac~ is highly 
speculative, but Marshall and Smith (1974) showed that, in 
mice, caudate tyrosine hydroxylase activity is depressed at 
36 hours of withdrawal, but returns to normal by 72 hours. 
Thus, one could predict that aggression emerges as the bi-
phasic . changes in tyrosine hydroxylase activity return to-
wards normal. 
2) Protracted Aggression 
Following the chronic administration of morphine, spon-
taneous aggression as well as the supersensitivity to apomor-
phine was evident at 30 days of withdrawal. This suggests 
that the neuronal changes associated with narcotic dependence 
and withdrawal are long-lasting phenomena. Lesioning of the 
nigro-striatal bundle (NSB), which is the major dopaminergic 
fiber tract, reduced the aggression, while lesioning the ad-
jacent medial forebrain bundle was ineffective. When a nor-
mally ineffective dose of apomorphine was administered to 
dependent rats with the NSB lesion, the aggression was re-
instated which demonstrated that the normal pre-synaptic 
nerve stimulation of receptors could be successfully sub-
stituted by a direct chemical stimulation in the lesioned 
rats and further demonstrated the presence of supersensitive 
dopamine receptors. The supersensitivity was also demon-
strated neurochemically since rats which were withdrawn for 
30 days required a significantly smaller dose of apomorphine 
to produce a decrease in striatal dopamine turnover (report-
ed in Gianutsos ~ ~·, 1974). 
C. Chronic Haloperidol 
Following prolonged treatment with haloperidol, rats 
exhibited an enhanced sensitivity to the actions of apomor-
phine and amphetamine in stereotypy and locomotor activity. 
Since these effects are believed to be dependent on DA stim-
ulation (Ernst, 1967; Snyder et al., 1970; Costa et al., 1972; 
Thornburg and Moore, 1973a), it may be proposed that a 
dopaminergic supersensitivity develops during chronic halo-
peridol treatment. Since haloperidol is believed to block 
dopamine receptors (Nyback ~ ~., 1968; Anden et al., 1970a; 
Koe, 1974), this supersensitivity may reflect a compensatory 
adaptation to the prolonged receptor blockade. This supersen-
sitivity was also demonstrated neurochemically by a shift 
to . the left in the apomorphine dose-response curve for re-
ducing dopamine turnover in the striatum. Normally inef fec-
tive doses of apomorphine were capaole of reducing striatal 
dopamine turnover after chronic haloperidol treatment. 
In addition, there was a marked shift to the left of the 
apomorphine-induced aggression dose-response curve after re-
peated injections with haloperidol. However, in constast to 
the effect of chronic morphine, there was no spontaneous or 
amphetamine-induced aggression after chronic haloperidol, de-
spite the presence of supersensitive dopamine receptors. It 
is interesting that amphetamine induces aggression after 
chronic morphine (Thor, 1969; Lal et al., 1971) or chronic 
ethanol (Mann and Lal, 1975) both of which are abused drugs, 
but failed to induce aggression after prolonged treatment 
with haloperidol, a non-abused drug. The reason for these 
effects is not clear, but several explanations may be offered. 
For example, it may be proposed that haloperidoi stabilizes 
the pre-synaptic dopamine neuronal membrane (Janssen, 1967). 
Such a stabilization may prevent the release of dopamine by 
stimulation of the nerve or by amphetamine so that the amount 
of dopamine reaching the receptor is insufficient to produce 
aggression. Such an effect, if it in fact occurs, would 
have to be long-lasting and specific for brain areas which 
are responsible for aggression, since other actions of am-
phetamine (stereotypy, locomotor stimulation) are enhanced 
after chronic haloperidol. A long-lasting alteration of pre-
synaptic dopamine mechanisms . may be an important aspect of 
the haloperidol action, working in concert with receptor 
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blockade for th~ alleviation of schizophrenia. Clearly, it 
would not oe oeneficial to treat schizophrenics with haloper-
idol only to produce supersensitive receptors, requiring ever 
increasing doses of an antagonist and which, in the absence 
of receptor blockade, would result in an exacerbation of 
symptoms when the drug was discontinued. 
Evidence to support this hypothesis is lacking. However, 
Seeman and Lee (1975) demonstrated that neuroleptics block 
the coupling between nerve impulse and dopamine release, which 
was correlated with anti-psychotic potency. Alternatively, 
the interaction between DA and other neurotransmitters (e.g. 
serotonin, ACh) may be different after chronic haloperidol 
or morphine (see below). Lastly, the supersensitivity oc-
curing after chronic haloperidol may be qualitatively or 
quantitatively different from the supersensitivity occuring 
after chronic morphine (see below). 
Long-term neuroleptic therapy reportedly results in 
tardive dyskinesias in humans which is associated with dop-
aminergic supersensitivity and a cholinergic subsensitivity 
(Klawans, k973; Gerlach~~., 1974). A similar relation-
ship was demonstrated with drug effects on locomotor activ-
ity in rats following chronic haloperidol in the present ex-
periment. The stimulation produced by dopaminergic agonists 
(amphetamine, apomorphine) was enhanced in these rats. A 
similar effect was reported in mice (Thornburg and Moore, 
1974; Von Voightlander ~al~, 1975). In addition, the 
stimulation of locomotor activity ~reduced by the antichol-
inergic, dexetimide, was likewise enhanced. Conversely, the 
decrease in locomotor activity produced by cholinergic stim-
ulation (pilocarpine) was antagonized after chronic treatment 
with haloperidol. A gneralized increase in CNS excitability 
could be proposed as the mechanism responsible for these ef-
fects, except that the effect of pentobarbital in reducing 
locomotor activity was identical in normal and in chronical-
ly haloperidol treated rats. This would also rule out an 
explanation based on interference with drug metabolism. 
The locomotor stimulation produced by both amphetamine 
(Costa£.!_ .21.·, 1972; Thornburg and Moore, 197~a; Hollister 
~al., 1974) and anticholinergics (Thornburg and Moore, 
1973b) is dependent on dopaminergic stimulation. However, 
this is not a general phenomenon, since the improvement of 
shuttle-box avoidance by amphetamine requires catecholamines, 
while the similar effect of the anticholinergic, scopolamine, 
' is not dependent on catecholamines (Rech and Moore, 1968). 
Several anticholinergics are known to block the reuptake of 
dopamine (Coyle and Snyder, 1969) and, although this has not 
been studied with dexetimide, it could provide an explanation 
for the enhanced stimulatory effects since the dopamine which 
would be prevented from returning to the pre~synaptic neuron 
for inactivation would react with supersensitive receptors. 
However, it has been demonstrated that anticholinergics pro-
duce their effects on locomotor stimulation by an antichol-
inergic rather than an uptake-blocking mechanism (Thornburg 
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and Moore, 1973c). Furth~rmore, the decreased effectiveness 
of pilocarpine could not be accounted for by a mechanism 
which is based on blockade of catecholamine uptake. Since 
cholinergic drugs antagonize the stimulation produced by 
dopaminergic drugs (Mennear, 1965), while anticholinergics 
apparently facilitate the expression of DA activity held in 
check by cholinergic stimulation, it may be concluded that 
the results can be explained by a reduced sensitivity of the 
cholinergic receptor as a result of chronic neuroleptic 
treatment (also see below). 
D. Comparison of Haloperidol and Morphine 
Haloperidol and morphine share a number of similar 
behavioral and biochemical actions related to dopamine. 
For example, both drugs produce a state of immobility 
(Costall and Naylor, 1974); blocR the stereotypy produced 
by dopaminergic agonists (Janssen~ al., 1965; Puri~ al., 
1973); block jumping produced by a combination of DOPA+ 
amphetamine (Colpaert~ al., 1975); inhibit conditioned 
avoidance responding (Niemegeers ~al., 1964); inhibit 
brain self stimulation (Wauquier ~al., 1974; 1975); and 
inhibit the aggression produced by DOPA + amphetamine (Lal 
~al., 1972) by shock (Lal~ !!l_., 1975a) and, as shown 
here, the aggression produced by apomorphine or morphine 
withdrawal. In addition, both morphine and haloperidol in-
crease the turnover of brain dopamine (see II.B.3); increase 
th~ activity of dopamine stimulated adenylate cyclase 
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(Iwatsubo and Clouet, 1975); and increase plasma prolactin 
levels while decreasing plasma luetinizing hormone levels 
(Clemens~ al., 1974; Dobrin and Mares, 1974). After 
chronic treatment with either drug, behavioral and neuro-
chemical evidence of dopaminergic supersensitivity is noted 
(this thesis and Puri and Lal, 1973a; 1974b; Tarsy and Bald-
essarini, 1973). In addition, repeated treatment with either 
drug results in locomotor stimulation during withdrawal (this 
thesis) and facilitates recovery from lesions of the lateral 
hypothalamus (Hynes~ al., 1975). Moreover, morphine with-
drawn rats are tolerant to the increase in striatal dopamine 
turnover produced by either drug (Puri and Lal, 1974a). 
However, equally striking are the differences between 
the two drugs. Most notable, of course, is the well recog-
nized ability of morphine to produce physical dependence and 
reinforcing properties. Recently, Glick and Cox (1975) de-
monstrated that very small doses of haloperidol would be self 
administered by the rat, but it is generally recognized that 
haloperidol is not abused and does not produce physical de-
pendence. In addition, the behavioral effects of morphine 
and haloperidol are differentially antagonized by different 
compounds. Anticholinergics reverse the blockade of aggres-
• 
sion produced by neuroleptics, but not that produced by mor-
phine. On the other hand, morphine's actions were antagon- · 
ized by naloxone, but haloperidol's were not. Similar re-
sults have been demonstrated for the catalepsy produced by 
narcotics and neuroleptics (Kuschinsky and Hornykiewicz, 
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1972; Costall and Naylor, 1974) and for the blockade of 
mouse jumping induced by DOPA + amphetamine (Colpaert et ~·, 
1975) and the blockade of brain self-stimulation (Wauquier 
et~., 1974; 1975) produced by either drug. This points up 
an important difference in the dopaminergic/cholinergic bal-
ance between these two compounds and suggests that the re-
duction of dopaminergic activity by morphine may be indirect. 
Furthermore, the ability of anticholinergics to reverse the 
neuroleptic-induced blockade of aggression was lost after 
chronic treatment. 
It was pointed out previously that chronic treatment 
with either haloperidol or morphine produces measurable 
dopaminergic supersensitivity, but only treatment with the 
latter results in spontaneous aggression. One possible ex-
planation has already been offered (see previous section). 
Alternatively, there may be differences in the supersensiti-
vity produced by the two drugs. Kuschinsky (1975) observed 
that morphine dependent rats failed to show an enhanced sen-
sitivity to apomorphine-induced stereotypy, while a dopa-
minergic supersensitivity was demonstrated neurochemically. 
Some unpublished, preliminary observations in our laboratory 
would be consistent with these result5. However, following 
chronic haloperidol, enhanced apomorphine-induced stereotypy 
is readily observed (this thesis and Schelkunov, 1967; 
Tarsy and Baldessarini, 1973). Furthermore, the supersensi-
tivity produced by morphine appears to be longer lasting 
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than the comparable supersensitivity produced by haloperidol 
(N.B. apomorphine-induced aggression appeared to fade 18 
days after stopping haloperidol, while the morphine effect 
lasted for at least 30 days of withdrawal). This suggests 
that morphine and haloperidol may produce a qualitatively 
different supersensitivity, ·perhaps by interacting with 
different types or groups of receptors. 
It should be remembered that after chronic haloperidol, 
a subsensitivity to cholinergic stimulation was noted. Since 
neuroleptics, as a result of DA receptor blockade, increase 
the release of ACh (Stadler ~ ~·, 1973; Guyenet ~ ~·, 
1975; McGeer ~ ~·, 1974) one may hypothesize a three stage 
process of adaptation to CNS DA receptor blockade. In the 
first stage, since blockade of DA receptors by neuroleptics 
reduces the stimulation of those receptors (and increases 
the release of ACh), the post-synaptic neuron would attempt 
to compensate by sending messages to the dopamine neuron to 
increase the synthesis and release of DA in order to over-
ride the effect of the neuroleptic or other drug. There is 
ample evidence that this occurs after neuroleptics (Anden 
~al., 1971; Carlsson and Lindqvist, 1963). Since this 
method is inefficient over the long-term, the post-synaptic 
neuron could also compensate by becoming supersensitive to 
stimulation by DA. In the meantime, the cholinergic sensi-
tive receptors could also compensate for the unusally large 
number of messages reaching them by becoming less sensitive 
to cholinergic stimulation. By these adaptations, a new 
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homeostatic balance is developed. · (Incidentally, if one 
was to speculate that an enhanced release of ACh from DA 
sensitive sites was responsible for the anti-aggression ac-
tion of the neuroleptics, it would explain the antagonism by 
anticholinergics of the neuroleptic effect.) Although this 
hypothesis was presented in ·terms of DA and ACh, it would 
work equally well for DA and serotonin (i.e., DA receptor 
blockade would reduce the need for serotonin to antagonize 
DA and so the serotonin neuron would decrease its activity. 
In the long run, one would predict that the serotonin recep-
tors ~~would become supersensitive due to a lack of stim-
ulation and this would contribute to the lack. of aggression 
during "withdrawal" of haloperidol). 
Morphine, on the other hand, may be thought of as in-
terfering with and modifying the normal compensatory proces-
es, so that a more drastic or entirely different mechanism 
for adaptation would be called into play. There are some 
differences in the effects of morphine and haloperidol on 
ACh. It is believed, for example, that morphine blocks the 
release of ACh (Beleslin and Polak, 1965), althpugh this ef-
feet has been questioned (Mullin and Phillis, 1974). A re-
sulting cholinergic supersensitivity has been proposed as 
being responsible for narcotic withdrawal (~aton, 1969). Al-
though it is known that ACh utilization is inr.reased durin g 
withdra~al of narcotics (Domino and Wilson. 1973), this ef-
fect does not appear to follow the temporal pattern of the 
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abstinence syndrome (Mullin and Phillis, 1974). It has been 
noted that neuroleptics accelerate the turnover of ACh in the 
striatum, but do not affect cortical ACh turnover (Trabucchi 
et al., 1974), while morphine decreases the turnover of ACh 
in the cortex, with no effect on the stria tum (Cheney ~ ~·, 
1974). This has been attributed to a combined direct effect 
on morphine on ACh neurons and an indirect effect mediated 
by DA (Cheney~~., 1974). Furthermore, Yarbrough (1974) 
was unable to demonstrate an increased sensitivity of corti-
cal neurons to ACh when measured six hours after a terminal 
injection of morphine, but the efficacy of atropine in 
blocking the effects of ACh was reduced (another apparent 
distinction between morphine and haloperidol, since the be-
havioral effects of anticholinergics were increased after 
chronic haloperidol). 
In spite of the seeming cholinergic supersensitivity, 
there are some inconsistencies. The ratio of the effective 
anti-aggression dose of pilocarpine to haloperidol in block-
ing apomorphine-induced aggression in naive rats was 2:1 
(5 mg/kg:2.5 mg/kg). The ratio of these drugs in blocking 
morphine withdrawal aggression was 16:1 (10 mg/kg:0.64 mg/kg). 
Thus, despite the fact that there is supposed to be a dopa-
minergic supersensitivity and a cholinergic supersensitivity 
during narcotic withdrawal, pilocarpine (cholinergic stimu-
lation) was relatively much less effective than dopaminergic 
receptor blockade in decreasing morphine withdrawal aggression 
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than in decreasing apomorphine-induced aggression in naive 
rats. Thus it may be proposed that the normal compensatory 
balance between ACh and DA is interferred with during morphine 
addiction and . the central cholinergic stimulation may not be 
relied upon following chronic morphine. In other words, while 
cholinergic receptors in the simpler circuitry of the periph-
eral nervous system may adapt by becoming more sensitive to 
cholinergic stimulation, central cholinergic neurons, which 
are under a more complex regulation, may be bypassed and be-
come functionally inoperative. If so, withdrawal aggression 
may be evident because of the functional lack of a cholinergic 
inhibitory system. 
In addition, morphine is known to increase the turnover 
of serotonin in the brain (Way ~ al., 1968; Yarbrough ~ ~·, 
1971; Haubrich and Blake, 1973). There is apparently no tol-
erance to this effect when rats are made dependent by mor-
phine injections (Bowers and Kleber, 1971). Administration 
of PCPA prevents the development of morphine tolerance and 
physical dependence (Way~ al., 1968). If one proposes that 
the increased turnover of serotonin is a consequence of in-
creased release of serotonin directly produced by morphine, 
this may contribute to the anti-aggression action of the drug 
and provide an explanation for the aggression during with-
drawal. It may be further assumed that this continual rel-
ease produces a decrease in sensitivy of serotonin receptors, 
analogous to the arguement made for suhsensitive cholinergic 
receptors after chronic haloperidol (above), and/or an addi-
140 
tional further compensatory increase in sensitivity of dopa-
mine receptors. Under this assumption, very sensitive DA re-
ceptors would be associated with subsensitive serotonergic 
receptors during morphine withdrawal, in contrast to the as-
sumption made for chronic haloperidol in which both sets of 
receptors were assumed to be supersensitive. 
Lastly, the recent discovery of endogenous morphine-
like peptides in the brain (Hughes, 1975) introduces another 
possible mechanism for the direct or indirect actions of 
narcotics. Although the exact significance of these endogen-
ous compounds is unclear at this time, their importance 
cannot be ruled out. 
VI SUMMARY AND CONCLUSIONS 
1. Apomorphine induced aggression in a dose-dependent man-
ner in naive rats. · The aggression was blocked, dose-depen-
dently, by haloperidol, oxyperomide and morphine and increased 
by amphetamine. These results suggest that the aggression 
is the result of hyperactivity of dopaminergic systems in the 
brain. 
2. The blockade of aggression by haloperidol or oxyperomide 
was reversed by anticholinergics, but not by naloxone. Mor-
phine's anti-aggression action was reversed by naloxone but 
not by anticholinergics. This suggests that the neuroleptics 
and morphine produce a blockade of aggression by different 
mechanisms, perhaps involving a cholinergic component in the 
case of neuroleptics. 
3. Apomorphine-induced aggression was blocked dose-dependent-
ly by pilocarpine and increased by dexetimide. In addition, 
it was enhanced by pretreatment with p-chloroamphetamine or 
clonidine, while the amphetamine effect was enhanced by cy-
proheptadine. These results suggest that the aggression is 
modulated by activity in cholinergic, serotonergic and. pos-
sibly, noradrenergic areas. Cholinergic and serotonergic stim-
ulation appears to inhibit aggression while noradrenergic 
stimulation may facilitate the aggression. 
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4. Morphine withdrawal aggression was noted when withdrawal 
was initiated by witholding of morphine injections. The ag-
gression was blocked by morphine, haloperidol or by lesions 
of the dopaminergic nigro-striatal bundle and was enhanced 
by apomorphine. When withdrawal was precipitated by naloxone, 
aggression was not observed .when other signs of withdrawal 
stress were noted. However, a small dose of apomorphine 
was able to elicit aggression when given as little as four 
hours after the last morphine injection. These results fur-
ther provide evidence that chronic morphine administration 
results in dopaminergic supersensitivity and that this is 
reflected in the withdrawal aggression, but ~uggests that 
mere removal of morphine from its "receptors" by naloxone is 
insufficient to elicit the aggression. 
5. Morphine withdrawal aggression was noted even 30 days af-
ter withdrawal was initiated and was enhanced by small doses 
apomorphine and blocked by nigro-striatal lesions, suggesting 
that the supersensitivity produced during narcotic dependence 
is a long-lasting phenomenon. 
6. Morphine withdrawal aggression pharmacologically resem-
bled apomorphine-induced aggression since both were enhanced 
by dexetimide, amphetamine and clonidine and both were re-
duced by haloperidol, morphine and pilocarpine. However, the 
blockade of aggression produced by haloperidol was reversed 
by anticholinergics in naive rats, but not in morphine-with-
drawnrats, suggesting that an alteration in a cholinergic 
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inhibitory system or in the balance between dopaminergic 
and cholinergic activity develops during the course of nar-
cotic addiction. 
7. Following discontinuation of long-term treatment with 
haloperidol, enhanced apomorphine or amphetamine induced ster-
eotypy or locomotor stimulation was observed, leading to the 
conclusion that this treatment induces supersensitivity of 
dopamine receptors. This was further supported by neuro-
chemical evidence which showed that the dose response curve 
for apomorphine-induced reduction in striatal dopamine turn-
over was shifted to the left after chronic treatment with 
haloperidol was discontinued. 
8. The dose of apomorphine required to elicit aggression 
was also markedly reduced after cessation of chronic haloper-
idol injections, supporting the hypothesis of dopaminergic 
supersensitivi~y as the mechanism for morphine withdrawal ag-
gression. In contrast to the effect of chronic morphine, 
there was no spontaneous o~ amphetamine-induced aggression 
after chronic haloperidol. These results suggest either that 
other mechanisms besides dopaminergic supersensitivity are 
necessary for morphine withdrawal aggression; or that the 
supersensitivity produced after these two treatments are 
dissimilar; or that after chronic haloperidol treatment there 
is interference with the process of transmitter release; or 
that there are differences in the balance between dopamine 
and other transmitters after treatment with the two drugs; or 
any combination of these factors. 
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9. Following chronic haloperidol, the stimulation of loco-
motor activity produced by dexetimide was increased and the 
locomotor depression produced by pilocarpine was decreased, 
while pentobarbital wasequi-effective in naive and chronica-
lly haloperidol treated rats. These results suggested that 
a cholinergic subsensitivity develops during chronic haloper-
idol treatment, perhaps as a compensatory mechanism. 
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